<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Calcified Tissue International via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Calcified Tissue International' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Calcified+Tissue+International&t=Calcified+Tissue+International&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 00:02:25 +0100</lastBuildDate>
        <item>
            <title>Soft Tissue Composition and the Risk of Low Bone Mineral Density: The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV-3), 2009</title>
            <link>http://www.medworm.com/index.php?rid=5661175&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy325l1720w737673%2F</link>
            <description>In conclusion, higher LM was associated with a lower risk of low BMD in both genders, while higher
 FM was associated with a higher risk of low BMD for men &amp;lt;50&amp;nbsp;years but not for women and men ≥50&amp;nbsp;years. The combined effects
 of LM and FM on BMD were gender- and menopause status–specific.
 
 
	Content Type Journal ArticleCategory Original ResearchPages 1-7DOI 10.1007/s00223-012-9573-xAuthors
		Kayoung Lee, Department of Family Medicine, Busan Paik Hospital, Inje University College of Medicine, 633-165 Kaegum-dong, Busan Jin-Gu, Busan, 614-735 South Korea
	

	
		Journal Calcified Tissue InternationalOnline ISSN 1432-0827Print ISSN 0171-967X (Source: Calcified Tissue International)</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661175</comments>
            <pubDate>Wed, 01 Feb 2012 17:12:58 +0100</pubDate>
            <guid isPermaLink="false">5661175</guid>        </item>
        <item>
            <title>Osteocyte Apoptosis and Absence of Bone Remodeling in Human Auditory Ossicles and Scleral Ossicles of Lower Vertebrates: A Mere Coincidence or Linked Processes?</title>
            <link>http://www.medworm.com/index.php?rid=5661176&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F241644t370v32lr0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Considering the pivotal role as bone mechanosensors ascribed to osteocytes in bone adaptation to mechanical strains, the present
 study analyzed whether a correlation exists between osteocyte apoptosis and bone remodeling in peculiar bones, such as human
 auditory ossicles and scleral ossicles of lower vertebrates, which have been shown to undergo substantial osteocyte death
 and trivial or no bone turnover after cessation of growth. The investigation was performed with a morphological approach under
 LM (by means of an in situ end-labeling technique) and TEM. The results show that a large amount of osteocyte apoptosis takes
 place in both auditory and scleral ossicles after they reach their final size. Additionally, no morphological signs of bone
 remodeling were obser...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5661176</comments>
            <pubDate>Tue, 31 Jan 2012 07:04:21 +0100</pubDate>
            <guid isPermaLink="false">5661176</guid>        </item>
        <item>
            <title>Femoral Neck Bone Strength Estimated by Hip Structural Analysis (HSA) in Swedish Caucasians Aged 6–90 Years</title>
            <link>http://www.medworm.com/index.php?rid=5639799&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv324586185237272%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Dual-energy X-ray absorptiometry hip scans of 1,760 population-based Caucasians, 599 girls and 642 boys aged 6–19&amp;nbsp;years and
 270 women and 249 men aged 20–90&amp;nbsp;years, were analyzed with the hip structural analysis (HSA) software to present age- and
 sex-specific normative HSA data of the femoral neck (FN). Measured traits included bone mineral density (BMD), cross-sectional
 area (CSA), section modulus (Z), periosteal diameter (PD), endosteal diameter (ED), cortical thickness (CT), and cross-sectional
 moment of inertia (CSMI). When plotting the measured traits versus age, the curves increased with higher ages until statistically
 significant break points were reached, for all traits at age 17 in girls and age 19 in boys. After the break points, PD and
 ED i...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639799</comments>
            <pubDate>Tue, 24 Jan 2012 07:54:00 +0100</pubDate>
            <guid isPermaLink="false">5639799</guid>        </item>
        <item>
            <title>Microcracks and Osteoclast Resorption Activity In Vitro</title>
            <link>http://www.medworm.com/index.php?rid=5639801&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu578h31704172w25%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;During bone remodeling osteoclasts resorb bone, thus removing material, e.g., damaged by microcracks, which arises as a result
 of physiological loading and could reduce bone strength. Such a process needs targeted bone resorption exactly at damaged
 sites. Osteocytic signaling plays a key role in this process, but it is not excluded that osteoclasts per se may possess toposensitivity
 to recognize and resorb damaged bone since it has been shown that resorption spaces are associated with microcracks. To address
 this question, we used an in vitro setup of a pure osteoclast culture and mineralized substrates with artificially introduced
 microcracks and microscratches. Histomorphometric analyses and statistical evaluation clearly showed that these defects had
 no effect ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639801</comments>
            <pubDate>Tue, 24 Jan 2012 07:53:59 +0100</pubDate>
            <guid isPermaLink="false">5639801</guid>        </item>
        <item>
            <title>Skeletal Analysis of the Long Bone Abnormality (lbab/lbab) Mouse, A Novel Chondrodysplastic C-Type Natriuretic Peptide Mutant</title>
            <link>http://www.medworm.com/index.php?rid=5639800&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F42243x7004g6813v%2F</link>
            <description>In this study, we analyzed the chondrodysplastic skeletal phenotype
 of lbab/lbab mice. At birth, lbab/lbab mice are only slightly shorter than their wild-type littermates. Nevertheless, lbab/lbab mice do not undergo a growth spurt, and their final body and bone lengths are only ~60% of those of wild-type mice. Histological
 analysis revealed that the growth plate in lbab/lbab mice, especially the hypertrophic chondrocyte layer, was significantly thinner than in wild-type mice. Overexpression of
 CNP in the cartilage of lbab/lbab mice restored their thinned growth plate, followed by the complete rescue of their impaired endochondral bone growth. Furthermore,
 the bone volume in lbab/lbab mouse was severely decreased and was recovered by CNP overexpression. On the other hand, the thickness ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639800</comments>
            <pubDate>Tue, 24 Jan 2012 07:53:59 +0100</pubDate>
            <guid isPermaLink="false">5639800</guid>        </item>
        <item>
            <title>Bisphosphonate Binding Affinity Affects Drug Distribution in Both Intracortical and Trabecular Bone of Rabbits</title>
            <link>http://www.medworm.com/index.php?rid=5611836&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj1213727w0rv35j8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Differences in the binding affinities of bisphosphonates for bone mineral have been proposed to determine their localizations
 and duration of action within bone. The main objective of this study was to test the hypothesis that mineral binding affinity
 affects bisphosphonate distribution at the basic multicellular unit (BMU) level within both cortical and cancellous bone.
 To accomplish this objective, skeletally mature female rabbits (n&amp;nbsp;=&amp;nbsp;8) were injected simultaneously with both low- and high-affinity bisphosphonate analogs bound to different fluorophores.
 Skeletal distribution was assessed in the rib, tibia, and vertebra using confocal microscopy. The staining intensity ratio
 between osteocytes contained within the cement line of newly formed rib osteons...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5611836</comments>
            <pubDate>Tue, 17 Jan 2012 07:17:45 +0100</pubDate>
            <guid isPermaLink="false">5611836</guid>        </item>
        <item>
            <title>Effect of Dosing Interval Duration of Intermittent Ibandronate Treatment on the Healing Process of Femoral Osteotomy in a Rat Fracture Model</title>
            <link>http://www.medworm.com/index.php?rid=5611837&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F20513176403rm1l1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The effects of bisphosphonate treatment schedule on fracture healing have not previously been tested. We evaluated the effect
 of ibandronate dosing interval duration on healing following surgical “fracture” (osteotomy) using a rat femoral fracture
 model. Six-week-old rats (n&amp;nbsp;=&amp;nbsp;160) underwent osteotomy and were then allocated into vehicle control (CNT) or an ibandronate treatment group: 5&amp;nbsp;μg/kg
 daily (DAY, 5&amp;nbsp;days/week), 75&amp;nbsp;μg/kg once every 3&amp;nbsp;weeks (I-3), 150&amp;nbsp;μg/kg once every 6&amp;nbsp;weeks (I-6), resulting in the same total
 ibandronate dose over the study. Rats were killed after 6 or 18&amp;nbsp;weeks. At 18&amp;nbsp;weeks, all fracture lines had disappeared in
 the CNT and I-6 groups; approximately 10% of fracture lines remained in th...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5611837</comments>
            <pubDate>Tue, 17 Jan 2012 07:17:44 +0100</pubDate>
            <guid isPermaLink="false">5611837</guid>        </item>
        <item>
            <title>Decreased Bone Mineral Density in Rats Rendered Follicle-Deplete by an Ovotoxic Chemical Correlates with Changes in Follicle-Stimulating Hormone and Inhibin A</title>
            <link>http://www.medworm.com/index.php?rid=5611838&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9016222750q1v0v3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Bone loss during perimenopause, an estrogen-sufficient period, correlates with elevated serum follicle-stimulating hormone
 (FSH) and decreased inhibins A and B. Utilizing a recently described ovotoxin-induced animal model of perimenopause characterized
 by a prolonged estrogen-replete period of elevated FSH, we examined longitudinal changes in bone mineral density (BMD) and
 their association with FSH. Additionally, serum inhibin levels were assessed to determine whether elevated FSH occurred secondary
 to decreased ovarian inhibin production and, if so, whether inhibins also correlated with BMD. BMD of the distal femur was
 assessed using dual-energy X-ray absorptiometry (DXA) over 19&amp;nbsp;months in Sprague-Dawley rats treated at 1&amp;nbsp;month with vehicle
 or 4-vinylc...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5611838</comments>
            <pubDate>Tue, 17 Jan 2012 07:17:43 +0100</pubDate>
            <guid isPermaLink="false">5611838</guid>        </item>
        <item>
            <title>Effects of Increasing Age, Dosage, and Duration of PTH Treatment on BMD Increase—A Meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=5599824&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8n8047341011571x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We studied the effects of increasing age, dosage, and duration of parathyroid hormone (PTH) treatment on changes in bone mineral
 density (BMD). Randomized placebo controlled trials on PTH treatment in men or women were retrieved from PubMed (1951 to present),
 Web of Science (1945 to present), or Embase (1974 to present). The search date was November 16, 2010. All studies comparing
 PTH treatment to either placebo or antiresorptive drugs—for example, bisphosphonates or hormone replacement therapy—were included.
 A total of 214 studies were identified in the initial search, and 15 of these trials were included. By metaregression analysis,
 we found that the increase in spine BMD (Z-score) after PTH treatment was blunted by increasing age (R
 2&amp;nbsp;=&amp;nbsp;0.27; 2p&amp;n...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599824</comments>
            <pubDate>Thu, 12 Jan 2012 06:41:19 +0100</pubDate>
            <guid isPermaLink="false">5599824</guid>        </item>
        <item>
            <title>A Class III Semaphorin (Sema3e) Inhibits Mouse Osteoblast Migration and Decreases Osteoclast Formation In Vitro</title>
            <link>http://www.medworm.com/index.php?rid=5573379&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl504057536128230%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Originally identified as axonal guidance cues, semaphorins are expressed throughout many different tissues and regulate numerous
 non-neuronal processes. We demonstrate that most class III semaphorins are expressed in mouse osteoblasts and are differentially
 regulated by cell growth and differentiation: Sema3d expression is increased and Sema3e expression decreased during proliferation
 in culture, while expression of Sema3a is unaffected by cell density but increases in cultures of mineralizing osteoblasts.
 Expression of Sema3a, -3e, and -3d is also differentially regulated by osteogenic stimuli; inhibition of GSK3β decreased expression
 of Sema3a and -3e, while 1,25-(OH)2D3 increased expression of Sema3e. Parathyroid hormone had no effect on expression of Sema3a, -...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573379</comments>
            <pubDate>Fri, 06 Jan 2012 16:49:38 +0100</pubDate>
            <guid isPermaLink="false">5573379</guid>        </item>
        <item>
            <title>Failure of Teriparatide in Treatment of Bone Complications of Adult Hypophosphatasia</title>
            <link>http://www.medworm.com/index.php?rid=5573380&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6005610g42101507%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-1DOI 10.1007/s00223-011-9562-5Authors
		Michel Laroche, Service de Rhumatologie, CHU Purpan, 1 place du Dr Baylac, TSA 40031, 30159 Toulouse Cedex 09, France
	

	
		Journal Calcified Tissue InternationalOnline ISSN 1432-0827Print ISSN 0171-967X (Source: Calcified Tissue International)</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573380</comments>
            <pubDate>Wed, 04 Jan 2012 16:51:30 +0100</pubDate>
            <guid isPermaLink="false">5573380</guid>        </item>
        <item>
            <title>Microarray Profiling of Diaphyseal Bone of Rats Suffering from Hypervitaminosis A</title>
            <link>http://www.medworm.com/index.php?rid=5573381&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Frhj8122g876nmg96%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Vitamin A is the only known compound that produces spontaneous fractures in rats. In an effort to resolve the molecular mechanism
 behind this effect, we fed young male rats high doses of vitamin A and performed microarray analysis of diaphyseal bone with
 and without marrow after 1&amp;nbsp;week, i.e., just before the first fractures appeared. Of the differentially expressed genes in
 cortical bone, including marrow, 98% were upregulated. In contrast, hypervitaminotic cortical bone without marrow showed reduced
 expression of 37% of differentially expressed genes. Gene ontology (GO) analysis revealed that only samples containing bone
 marrow were associated with a GO term, which principally represented extracellular matrix. This is consistent with the histological
 finding...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573381</comments>
            <pubDate>Wed, 04 Jan 2012 06:48:19 +0100</pubDate>
            <guid isPermaLink="false">5573381</guid>        </item>
        <item>
            <title>A Polymorphism in a Gene Encoding Perilipin 4 Is Associated with Height but not with Bone Measures in Individuals from the Framingham Osteoporosis Study</title>
            <link>http://www.medworm.com/index.php?rid=5562616&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm5182x074u22827m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There is increasing interest in identifying new pathways and candidate genes that confer susceptibility to osteoporosis. There
 is evidence that adipogenesis and osteogenesis may be related, including a common bone marrow progenitor cell for both adipocytes
 and osteoblasts. Perilipin 1 (PLIN1) and Perilipin 4 (PLIN4) are members of the PATS family of genes and are involved in lipolysis of intracellular lipid deposits. A previous study
 reported gender-specific associations between one polymorphism of PLIN1 and bone mineral density (BMD) in a Japanese population. We hypothesized that polymorphisms in PLIN1 and PLIN4 would be associated with bone measures in adult Caucasian participants of the Framingham Osteoporosis Study (FOS). We genotyped
 1,206 male and 1,445 female...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5562616</comments>
            <pubDate>Fri, 30 Dec 2011 16:49:54 +0100</pubDate>
            <guid isPermaLink="false">5562616</guid>        </item>
        <item>
            <title>Knee Arthroplasty and Risk of Hip Fracture: A Population-Based, Case–Control Study</title>
            <link>http://www.medworm.com/index.php?rid=5527602&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd51686000086px25%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The majority of knee arthroplasties (KAs) are performed in patients with osteoarthritis (OA). Although bone mass may be increased
 in these patients, subjects with knee OA may have an increased risk of hip fracture, possibly due to an increased severity
 of falls. However, in patients with KAs, risk of hip fracture has not been studied extensively. We evaluated the association
 between KAs and hip fracture risk in a population-based case–control study using the Dutch PHARMO Record Linkage System (1991–2002,
 n&amp;nbsp;=&amp;nbsp;33,104). Cases were patients with a first admission for hip fracture; controls were matched by age, gender, and geographic
 location. Neither group had a previous history of fracture. Time since first KA was calculated. Analyses were adjusted for
 ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5527602</comments>
            <pubDate>Sat, 17 Dec 2011 17:04:19 +0100</pubDate>
            <guid isPermaLink="false">5527602</guid>        </item>
        <item>
            <title>Absolute Fracture-Risk Prediction by a Combination of Calcaneal Quantitative Ultrasound and Bone Mineral Density</title>
            <link>http://www.medworm.com/index.php?rid=5516585&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F76h700q2t44w55k2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Quantitative ultrasound measurement (QUS) and bone mineral density (BMD) have each been shown to predict fracture risk in
 women. The present study examined whether a combination of QUS and BMD could improve the predictive accuracy of fracture risk.
 This is a population-based prospective study which involved 454 women and 445 men aged 62–89&amp;nbsp;years. Femoral neck BMD (FNBMD)
 was measured by DXA and calcaneal QUS was measured as broadband ultrasound attenuation (BUA) by a CUBA sonometer. Fragility
 fracture was ascertained by X-ray reports during the follow-up period, which took place between mid-1989 and 2009. During
 the follow-up period (median 13&amp;nbsp;years, range 11–15), 75 men and 154 women sustained a fragility fracture. In women, the model
 with FNBMD and...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516585</comments>
            <pubDate>Fri, 16 Dec 2011 17:29:02 +0100</pubDate>
            <guid isPermaLink="false">5516585</guid>        </item>
        <item>
            <title>Genetic Polymorphisms of the Wnt Receptor LRP5 are Differentially Associated with Trochanteric and Cervical Hip Fractures</title>
            <link>http://www.medworm.com/index.php?rid=5516586&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx7365176x2wr58r1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Epidemiological studies suggest that cervical and trochanteric hip fractures have different pathogenesis. We tested the hypothesis
 that genetic factors have different influences on both types of fractures. Ten polymorphisms of genes known to play an important
 role in skeletal homeostasis [estrogen receptor alpha (ESR1), aromatase (CYP19A1), type I collagen (COL1A1), and lipoprotein receptor-related protein 5 (LRP5)] were analyzed in 471 Spanish patients with fragility hip fractures. Two polymorphisms of the LRP5 gene (rs7116604 and rs3781600) were associated with the type of fracture (P&amp;nbsp;=&amp;nbsp;0.0085 and 0.0047, respectively). The presence of rare alleles at each locus was associated with trochanteric fractures
 over cervical fractures (OR&amp;nbsp;=&amp;nbsp;1.7 in indi...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516586</comments>
            <pubDate>Tue, 13 Dec 2011 17:06:41 +0100</pubDate>
            <guid isPermaLink="false">5516586</guid>        </item>
        <item>
            <title>Antiosteoporotic Drugs and Incidence of Type 2 Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=5507211&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7455w54128777756%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s00223-011-9555-4Authors
		Ippei Kanazawa, Internal Medicine 1, Shimane University Faculty of Medicine, Shimane, Japan
	

	
		Journal Calcified Tissue InternationalOnline ISSN 1432-0827Print ISSN 0171-967X (Source: Calcified Tissue International)</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507211</comments>
            <pubDate>Sat, 10 Dec 2011 16:54:21 +0100</pubDate>
            <guid isPermaLink="false">5507211</guid>        </item>
        <item>
            <title>Longitudinal Assessment of In Vivo Bone Dynamics in a Mouse Tail Model of Postmenopausal Osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=5507212&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxk40347014g4u700%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recently, it has been shown that transient bone biology can be observed in vivo using time-lapse micro-computed tomography
 (μCT) in the mouse tail bone. Nevertheless, in order for the mouse tail bone to be a model for human disease, the hallmarks
 of any disease must be mimicked. The aim of this study was to investigate whether postmenopausal osteoporosis could be modeled
 in caudal vertebrae of C57Bl/6&amp;nbsp;mice, considering static and dynamic bone morphometry as well as mechanical properties, and
 to describe temporal changes in bone remodeling rates. Twenty C57Bl/6&amp;nbsp;mice were ovariectomized (OVX, n&amp;nbsp;=&amp;nbsp;11) or sham-operated (SHM, n&amp;nbsp;=&amp;nbsp;9) and monitored with in vivo μCT on the day of surgery and every 2&amp;nbsp;weeks after, up to 12&amp;nbsp;weeks. Ther...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5507212</comments>
            <pubDate>Thu, 08 Dec 2011 18:24:46 +0100</pubDate>
            <guid isPermaLink="false">5507212</guid>        </item>
        <item>
            <title>The Effect of Oral Glucose Tolerance Test on Serum Osteocalcin and Bone Turnover Markers in Young Adults</title>
            <link>http://www.medworm.com/index.php?rid=5488912&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Faxh8h7766k353517%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Osteocalcin (OC) is an osteoblast-derived protein implicated in the regulation of glucose tolerance and energy metabolism.
 This endocrine function has been suggested to be exerted via its undercarboxylated form, which has been shown to induce expression
 of adiponectin, insulin, and islet cell proliferation in mice. Furthermore, insulin has recently been shown to regulate the
 biological activity of OC in bone. Our aim was to explore the association between glucose and bone metabolism by evaluating
 the effect of a standard 75&amp;nbsp;g oral glucose tolerance test (OGTT) on serum OC, carboxylated OC (cOC) and bone-turnover markers
 (BTMs) C terminal telopeptide (βCTX-I) and N terminal propeptide (PINP) of type I collagen and tartrate-resistant acid phosphatase 5b (TRACP5...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5488912</comments>
            <pubDate>Wed, 07 Dec 2011 10:47:18 +0100</pubDate>
            <guid isPermaLink="false">5488912</guid>        </item>
        <item>
            <title>Evaluation of Methylation Status of the eNOS Promoter at Birth in Relation to Childhood Bone Mineral Content</title>
            <link>http://www.medworm.com/index.php?rid=5488911&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjr67u6150wm63v17%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Our previous work has shown associations between childhood adiposity and perinatal methylation status of several genes in
 umbilical cord tissue, including endothelial nitric oxide synthase (eNOS). There is increasing evidence that eNOS is important
 in bone metabolism; we therefore related the methylation status of the eNOS gene promoter in stored umbilical cord to childhood
 bone size and density in a group of 9-year-old children. We used Sequenom MassARRAY to assess the methylation status of two
 CpGs in the eNOS promoter, identified from our previous study, in stored umbilical cords of 66 children who formed part of
 a Southampton birth cohort and who had measurements of bone size and density at age 9&amp;nbsp;years (Lunar DPXL DXA instrument). Percentage
 methylation v...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5488911</comments>
            <pubDate>Wed, 07 Dec 2011 10:47:18 +0100</pubDate>
            <guid isPermaLink="false">5488911</guid>        </item>
        <item>
            <title>Ectopic Expression of SOX9 in Osteoblasts Alters Bone Mechanical Properties</title>
            <link>http://www.medworm.com/index.php?rid=5488913&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F431601101nj4k627%2F</link>
            <description>In conclusion, our study implies that SOX9 activity
 has to be tightly regulated in the adult skeleton to ensure optimal bone quality.
 
 
	Content Type Journal ArticleCategory Original ResearchPages 1-14DOI 10.1007/s00223-011-9550-9Authors
		Bojian Liang, Department of Orthopaedics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USAMeghan M. Cotter, Department of Anatomy, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USADongxing Chen, Department of Orthopaedics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USAChristopher J. Hernandez, Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY 14853, USAGuang Zhou, Department of Genetics, Case Western Reserve University, 10900 ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5488913</comments>
            <pubDate>Mon, 05 Dec 2011 17:41:44 +0100</pubDate>
            <guid isPermaLink="false">5488913</guid>        </item>
        <item>
            <title>Acute Myocardial Infarction and Atherosclerosis of the Coronary Arteries in Patients Treated with Drugs Against Osteoporosis: Calcium in the Vessels and not the Bones?</title>
            <link>http://www.medworm.com/index.php?rid=5450795&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2581551036301066%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We studied the association between bisphosphonate use and risk of acute myocardial infarction (AMI) or atherosclerosis of
 the coronary vessels using a nationwide retrospective cohort from Denmark. All users of bisphosphonates and other drugs against
 osteoporosis between 1996 and 2006 (n&amp;nbsp;=&amp;nbsp;103,562) comprised the exposed group and three age- and gender-matched controls from the general population (n&amp;nbsp;=&amp;nbsp;310,683), the unexposed group. The main outcomes were occurrence of AMI or atherosclerosis of the coronary vessels. An
 excess risk of AMI was seen in users of alendronate compared to the unexposed. However, an inverse dose–response relationship
 was seen, with an increased risk in those with low adherence (≤0.66 DDD, HR&amp;nbsp;=&amp;nbsp;1.50, 95% CI 1.2...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5450795</comments>
            <pubDate>Fri, 25 Nov 2011 17:58:37 +0100</pubDate>
            <guid isPermaLink="false">5450795</guid>        </item>
        <item>
            <title>Skeletal Remodeling Following Clinically Relevant Radiation-Induced Bone Damage Treated with Zoledronic Acid</title>
            <link>http://www.medworm.com/index.php?rid=5411367&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy53k232320t8hq07%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Our aim was to determine if zoledronic acid (ZA) changes 45Ca pharmacokinetics and bone microstructure in irradiated, ovary-intact (I) and irradiated, ovariectomized mice (OVX), two
 groups with different patterns of skeletal damage. The hind limbs of I and OVX BALB/c mice received a single 16-Gy radiation
 dose, simulating pre- and postmenopausal female cancer patients undergoing radiation treatment. All I and OVX mice were radiolabeled
 with 15&amp;nbsp;μCi 45Ca. Mice were treated with or without a 0.5&amp;nbsp;mg/kg injection of ZA. The time course of bone mineral remodeling was evaluated
 using a fecal 45Ca assay, measured by liquid scintillation. A group of nonirradiated, intact mice were used for the longitudinal evaluation
 of 45Ca biodistribution. Distal femur bone his...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411367</comments>
            <pubDate>Mon, 14 Nov 2011 16:58:05 +0100</pubDate>
            <guid isPermaLink="false">5411367</guid>        </item>
        <item>
            <title>Vitamin K2 Improves Renal Function and Increases Femoral Bone Strength in Rats with Renal Insufficiency</title>
            <link>http://www.medworm.com/index.php?rid=5411368&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F62872062554227xl%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Renal insufficiency induces cortical bone loss in rats. The present study examined the influence of vitamin K2 on renal function, cortical bone mass, and bone strength in rats with renal insufficiency. Thirty male Sprague-Dawley rats
 (8&amp;nbsp;weeks old) were randomized by the stratified weight method to the following three groups of 10 animals each: sham operation
 (control), 5/6 nephrectomy, and 5/6 nephrectomy&amp;nbsp;+&amp;nbsp;oral vitamin K2 (menaquinone-4, menatetrenone, 30&amp;nbsp;mg/kg, 5&amp;nbsp;days/week). Treatment was initiated 10&amp;nbsp;days after surgery. After 6&amp;nbsp;weeks of treatment,
 samples of serum, urine, and bone (femur and tibia) were obtained. Renal function was evaluated, bone histomorphometric analysis
 was performed on the tibial diaphysis, and the bone min...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411368</comments>
            <pubDate>Sat, 12 Nov 2011 06:48:41 +0100</pubDate>
            <guid isPermaLink="false">5411368</guid>        </item>
        <item>
            <title>The Risk of a Second Hip Fracture in Patients after Their First Hip Fracture</title>
            <link>http://www.medworm.com/index.php?rid=5411369&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6nn514wx1323j643%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We investigated the incidence of additional fractures and the rate of prescription of osteoporotic pharmacotherapy after an
 initial hip fracture. We surveyed female patients aged 65 and over who sustained their first hip fracture between January
 1, 2006, and December 31, 2007, treated at 25 hospitals in five geographic areas in Japan. Data for 1&amp;nbsp;year after the first
 hip fracture were collected from medical records, and questionnaires were mailed to all patients. In total, 2,663 patients
 were enrolled, and 335 patients were excluded based on exclusion criteria. The analysis was performed on 2,328 patients. During
 the 1-year follow-up period 160 fractures occurred in 153 patients and 77 subsequent hip fractures occurred in 77 patients.
 The incidence of all addi...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411369</comments>
            <pubDate>Fri, 11 Nov 2011 06:55:56 +0100</pubDate>
            <guid isPermaLink="false">5411369</guid>        </item>
        <item>
            <title>Association Study of Polymorphisms in the SOST Gene Region and Parameters of Bone Strength and Body Composition in Both Young and Elderly Men: Data from the Odense Androgen Study</title>
            <link>http://www.medworm.com/index.php?rid=5411370&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp53604524l2r7171%2F</link>
            <description>This study aimed at a further understanding of the importance of two previously studied single-nucleotide polymorphisms in
 the SOST gene, rs10534024 (SRP3) and rs9902563 (SRP9), in the Odense Androgen Study (OAS) cohort. This cohort includes a total of
 1,383 Danish men from two different age groups, 20–29&amp;nbsp;years (n&amp;nbsp;=&amp;nbsp;783) and 60–74&amp;nbsp;years (n&amp;nbsp;=&amp;nbsp;600), and is well characterized. Subjects were phenotyped for BMD at several sites and additionally for body composition
 and hip geometric parameters. In a combined analysis of the young and the elderly OAS, no associations were found for SRP3
 either with BMD or with hip geometry. Instead, we found that this polymorphism had a relatively large effect on weight (–1.149&amp;nbsp;kg)
 and body mass index (–0.389&amp;nbsp;...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5411370</comments>
            <pubDate>Thu, 10 Nov 2011 16:50:50 +0100</pubDate>
            <guid isPermaLink="false">5411370</guid>        </item>
        <item>
            <title>FRAX® with and without Bone Mineral Density</title>
            <link>http://www.medworm.com/index.php?rid=5390742&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh129674hw1n88166%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The use of FRAX, particularly in the absence of BMD, has been the subject of some debate and is the focus of this review.
 The clinical risk factors used in FRAX have high validity as judged from an evidence-based assessment and identify a risk
 that is responsive to pharmaceutical intervention. Moreover, treatment effects, with the possible exception of alendronate,
 are not dependent on baseline BMD and strongly suggest that FRAX identifies high-risk patients who respond to pharmaceutical
 interventions. In addition, the selection of high-risk individuals with FRAX, without knowledge of BMD, preferentially selects
 for low BMD. The prediction of fractures with the use of clinical risk factors alone in FRAX is comparable to the use of BMD
 alone to predict fractures an...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5390742</comments>
            <pubDate>Sat, 05 Nov 2011 17:09:46 +0100</pubDate>
            <guid isPermaLink="false">5390742</guid>        </item>
        <item>
            <title>Structural Water in Carbonated Hydroxylapatite and Fluorapatite: Confirmation by Solid State 2H NMR</title>
            <link>http://www.medworm.com/index.php?rid=5390743&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0076qp84157425p3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Water is well recognized as an important component in bone, typically regarded as a constituent of collagen, a pore-filling
 fluid in bone, and an adsorbed species on the surface of bone crystallites. The possible siting and role of water within the
 structure of the apatite crystallites have not been fully explored. In our experiments, carbonated hydroxyl- and fluorapatites
 were prepared in D2O and characterized by elemental analysis, thermal gravimetric analysis, powder X-ray diffraction, and infrared and Raman
 spectroscopy. Two hydroxylapatites and two fluorapatites, with widely different amounts of carbonate were analyzed by solid
 state 2H NMR spectroscopy using the quadrupole echo pulse sequence, and each spectrum showed one single line as well as a low-intensit...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5390743</comments>
            <pubDate>Sat, 05 Nov 2011 17:09:44 +0100</pubDate>
            <guid isPermaLink="false">5390743</guid>        </item>
        <item>
            <title>Occurrence of Gastrointestinal Cancer in Users of Bisphosphonates and Other Antiresorptive Drugs Against Osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=5325822&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn4634x54x962l547%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We studied the association between bisphosphonate use and risk of gastrointestinal (GI) cancers in a nationwide retrospective
 cohort from Denmark. All users of bisphosphonates and other drugs against osteoporosis between 1996 and 2006 (n&amp;nbsp;=&amp;nbsp;103,562) were used as the exposed group, with three age- and gender-matched controls from the general population (n&amp;nbsp;=&amp;nbsp;310,683) as the nonexposed group. The main outcome was occurrence of cancer of the esophagus, ventricle, small intestine,
 colon, pancreas, gallbladder or bile duct, or liver. Except for colon cancer, most of the GI cancers were rare. For clodronate
 and raloxifene, no excess risk was present for any of the GI cancers. For alendronate, an excess risk of esophageal and liver
 cancer was observed; ho...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5325822</comments>
            <pubDate>Sat, 15 Oct 2011 15:46:35 +0100</pubDate>
            <guid isPermaLink="false">5325822</guid>        </item>
        <item>
            <title>Notch Regulation of Bone Development and Remodeling and Related Skeletal Disorders</title>
            <link>http://www.medworm.com/index.php?rid=5325821&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx06886464034046l%2F</link>
            <description>In conclusion, Notch is a regulator of skeletal development
 and bone remodeling, and abnormal Notch signaling is associated with developmental and postnatal skeletal disorders.
 
 
	Content Type Journal ArticleCategory ReviewPages 1-7DOI 10.1007/s00223-011-9541-xAuthors
		Stefano Zanotti, Department of Research, Saint Francis Hospital and Medical Center, 114 Woodland Street, Hartford, CT 06105, USAErnesto Canalis, Department of Research, Saint Francis Hospital and Medical Center, 114 Woodland Street, Hartford, CT 06105, USA
	

	
		Journal Calcified Tissue InternationalOnline ISSN 1432-0827Print ISSN 0171-967X (Source: Calcified Tissue International)</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5325821</comments>
            <pubDate>Sat, 15 Oct 2011 15:46:35 +0100</pubDate>
            <guid isPermaLink="false">5325821</guid>        </item>
        <item>
            <title>The Association of Body Composition and Sex Hormones with Quantitative Ultrasound Parameters at the Calcaneus and Phalanxes in Elderly Women</title>
            <link>http://www.medworm.com/index.php?rid=5317300&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd080185453508406%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We investigated the associations of body composition and sex hormones with quantitative ultrasound (QUS) parameters carried
 out at different skeletal sites. In 897 postmenopausal women (64.1&amp;nbsp;±&amp;nbsp;6.6&amp;nbsp;years) we measured QUS at the calcaneus (stiffness)
 by Achilles-GE and at phalanxes (amplitude-dependent speed of sound [AD-SOS], bone transmission time [BTT], and ultrasound
 bone profile index [UBPI]) by Bone Profiler-IGEA. In all subjects we measured fat mass (FM), lean mass (LM), android fat,
 and gynoid fat by DXA. In all subjects we also assessed serum testosterone (T), estradiol (E2), sex-hormone binding globulin, free estrogen index (FEI), free androgen index, 25-hydroxyvitamin D (25OHD), bone alkaline
 phosphatase (B-ALP), and type I collagen β carb...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5317300</comments>
            <pubDate>Tue, 11 Oct 2011 05:48:40 +0100</pubDate>
            <guid isPermaLink="false">5317300</guid>        </item>
        <item>
            <title>Absence of Glutamine Supplementation Prevents Differentiation of Murine Calvarial Osteoblasts to a Mineralizing Phenotype</title>
            <link>http://www.medworm.com/index.php?rid=5298458&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk75p042w42520483%2F</link>
            <description>In this study we investigate which common cell nutrients
 are required for the proliferating and mineralizing stages of osteoblast differentiation. Medium containing 5.5&amp;nbsp;mM glucose
 was sufficient to achieve maximal proliferation of primary calvarial osteoblasts and human osteoblast cell lines, with some
 added benefit of additional glutamine supplementation. However, when cells were stimulated to mineralize, glucose was insufficient
 to support their energetic requirements. Only when cells were supplemented with glucose together with glutamine were high
 levels of osteocalcin expression observed together with mineralized nodules in culture, suggesting that this would be a useful
 combination to assess in cultures of primary human osteoblasts to determine whether it may have beneficia...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298458</comments>
            <pubDate>Wed, 05 Oct 2011 05:49:34 +0100</pubDate>
            <guid isPermaLink="false">5298458</guid>        </item>
        <item>
            <title>Influence of Polymorphisms in the RANKL/RANK/OPG Signaling Pathway on Volumetric Bone Mineral Density and Bone Geometry at the Forearm in Men</title>
            <link>http://www.medworm.com/index.php?rid=5288072&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn64q84748336016x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We sought to determine the influence of single-nucleotide polymorphisms (SNPs) in RANKL, RANK, and OPG on volumetric bone mineral density (vBMD) and bone geometry at the radius in men. Pairwise tag SNPs (r
 2&amp;nbsp;≥&amp;nbsp;0.8) for RANKL (n&amp;nbsp;=&amp;nbsp;8), RANK (n&amp;nbsp;=&amp;nbsp;44), and OPG (n&amp;nbsp;=&amp;nbsp;22) and five SNPs near RANKL and OPG strongly associated with areal BMD in genomewide association studies were previously genotyped in men aged 40–79&amp;nbsp;years in
 the European Male Ageing Study (EMAS). Here, these SNPs were analyzed in a subsample of men (n&amp;nbsp;=&amp;nbsp;589) who had peripheral quantitative computed tomography (pQCT) performed at the distal (4%) and mid-shaft (50%) radius.
 Estimated parameters were total and trabecular vBMD (mg/mm3) and cross-sectiona...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5288072</comments>
            <pubDate>Sun, 02 Oct 2011 05:49:41 +0100</pubDate>
            <guid isPermaLink="false">5288072</guid>        </item>
        <item>
            <title>Vitamin D Status in Israeli Subjects before the Initiation and after the Cessation of Vitamin D Supplements</title>
            <link>http://www.medworm.com/index.php?rid=5288071&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F79368437524552q8%2F</link>
            <description>This study
 assessed vitamin D status at different time intervals following the cessation of treatment. The database of Clalit-Health-Services
 (CHS), a not-for-profit HMO covering more than half of the Israeli population, was retrospectively searched for all members
 with available serum 25OHD test results in 2009 (245,493). We then identified those who filled any cholecalciferol prescription
 in 2008–2009 (121,817). Subjects were included in the final analysis only if they started treatment in 2009, had serum 25OHD&amp;nbsp;&amp;lt;&amp;nbsp;50&amp;nbsp;nmol/l
 before the first prescription in 2009, and had at least one additional test result after the last dated prescription in 2009
 (5,461). Serum 25OHD increased from 32&amp;nbsp;±&amp;nbsp;11&amp;nbsp;nmol/l at baseline to 58.6&amp;nbsp;±&amp;nbsp;22.3&amp;nbsp;nmol/l a...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5288071</comments>
            <pubDate>Sun, 02 Oct 2011 05:49:41 +0100</pubDate>
            <guid isPermaLink="false">5288071</guid>        </item>
        <item>
            <title>Osteocalcin Gene Expression Is Regulated by Wild-Type p53</title>
            <link>http://www.medworm.com/index.php?rid=5288073&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj41519571x836136%2F</link>
            <description>In this study we investigated the role of
 p53 in the regulation of human osteocalcin gene expression. We observed that osteocalcin promoter activity could be upregulated
 by both exogenous and endogenous p53 and downregulated by p53-specific small interfering RNA. DNA affinity immunoblotting
 assay showed that p53 can bind to the human osteocalcin promoter in vitro. We further identified a p53 response element within
 the osteocalcin promoter region using a chromatin immunoprecipitation assay. Furthermore, we observed an additive effect of
 p53 and VDR on the regulation of osteocalcin promoter activity. Our findings suggest that p53 may directly target the human
 osteocalcin gene and positively affect osteocalcin gene expression.
 
 
	Content Type Journal ArticleCategory Original Research...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5288073</comments>
            <pubDate>Sat, 01 Oct 2011 05:45:10 +0100</pubDate>
            <guid isPermaLink="false">5288073</guid>        </item>
        <item>
            <title>In Vitro Generation of Mature Human Osteoclasts</title>
            <link>http://www.medworm.com/index.php?rid=5288074&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq778qt8w42272413%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mononuclear precursors of human osteoclasts are found in the CD14+ monocyte fraction of circulating peripheral blood mononuclear cells (PBMCs). It is possible to generate osteoclasts in vitro
 from PBMCs cultured with macrophage colony-stimulating factor and receptor activator for nuclear factor κB ligand. In these
 cultures, however, it is not possible to distinguish the effect of a specific agent on osteoclast resorption activity as opposed
 to osteoclast differentiation. To produce a population of mature human osteoclasts to study osteoclast lacunar resorption
 specifically, we cultured CD14+ human monocytes on hydrophobic dishes in order to generate and maintain osteoclasts in suspension prior to culturing them
 on coverslips and dentine slices. Multinucleated cell...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5288074</comments>
            <pubDate>Fri, 30 Sep 2011 05:52:22 +0100</pubDate>
            <guid isPermaLink="false">5288074</guid>        </item>
        <item>
            <title>Significant Association between Common Polymorphisms in the Aromatase Gene CYP19A1 and Bone Mineral Density in Postmenopausal Women</title>
            <link>http://www.medworm.com/index.php?rid=5276421&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm343772223t61k8q%2F</link>
            <description>In conclusion, common genetic variations within the CYP19A1 gene are significantly associated with aBMD in postmenopausal Caucasian women.
 
 
	Content Type Journal ArticleCategory Original ResearchPages 1-8DOI 10.1007/s00223-011-9535-8Authors
		B. H. Mullin, Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA, AustraliaK. W. Carter, Telethon Institute for Child Health Research, UWA Centre for Child Health Research, University of Western Australia, Nedlands, WA, AustraliaJ. R. Lewis, Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA, AustraliaE. Ingley, Cell Signalling Group, Laboratory for Cancer Medicine, Western Australia Institute for Medical Research and Centre for Medical Research, University of Western Australia, ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5276421</comments>
            <pubDate>Wed, 28 Sep 2011 05:52:28 +0100</pubDate>
            <guid isPermaLink="false">5276421</guid>        </item>
        <item>
            <title>Abrogation of Cbl–PI3K Interaction Increases Bone Formation and Osteoblast Proliferation</title>
            <link>http://www.medworm.com/index.php?rid=5276422&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5278q2u81k462x73%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cbl is an adaptor protein and E3 ligase that plays both positive and negative roles in several signaling pathways that affect
 various cellular functions. Tyrosine 737 is unique to Cbl and phosphorylated by Src family kinases. Phosphorylated CblY737
 creates a binding site for the p85 regulatory subunit of phosphatidylinositol 3 kinase (PI3K) that also plays an important
 role in the regulation of bone homeostasis. To investigate the role of Cbl–PI3K interaction in bone homeostasis, we examined
 knock-in mice in which the PI3K binding site on Cbl was ablated due to the substitution of tyrosine 737 to phenylalanine (CblYF/YF, YF mice). We previously reported that bone volume in these mice is increased due to decreased osteoclast function (Adapala
 et al., J Biol Chem 2...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5276422</comments>
            <pubDate>Wed, 28 Sep 2011 05:52:27 +0100</pubDate>
            <guid isPermaLink="false">5276422</guid>        </item>
        <item>
            <title>Architecture and Microstructure of Cortical Bone in Reconstructed Canine Mandibles After Bone Transport Distraction Osteogenesis</title>
            <link>http://www.medworm.com/index.php?rid=5240821&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F86pp24322ph4p180%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Reconstruction of the canine mandible using bone transport distraction osteogenesis has been shown to be a suitable method
 for correcting segmental bone defects produced by cancer, gunshots, and trauma. Although the mechanical quality of the new
 regenerate cortical bone seems to be related to the mineralization process, several questions regarding the microstructural
 patterns of the new bony tissue remain unanswered. The purpose of this study was to quantify any microstructural differences
 that may exist between the regenerate and control cortical bone. Five adult American foxhound dogs underwent unilateral bone
 transport distraction of the mandible to repair bone defects of 30–35&amp;nbsp;mm. Animals were killed 12&amp;nbsp;weeks after the beginning
 of the consolidatio...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5240821</comments>
            <pubDate>Fri, 16 Sep 2011 16:44:05 +0100</pubDate>
            <guid isPermaLink="false">5240821</guid>        </item>
        <item>
            <title>The Vitamin D Analog 1α,25-Dihydroxy-2β-(3-Hydroxypropyloxy) Vitamin D3 (Eldecalcitol) is a Potent Regulator of Calcium and Phosphate Metabolism</title>
            <link>http://www.medworm.com/index.php?rid=5240822&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq6rv48g613360038%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The vitamin D analog 1α,25-dihydroxy-2β-(3-hydroxypropyloxy)vitamin D3 (ED-71 or eldecalcitol) has been developed for treatment of osteoporosis, but its effects on mineral metabolism have not
 been investigated in detail. In the present study, we compared the effects of eldecalcitol and calcitriol on calcium (Ca)
 and phosphate (Pi) handling in rats. Oral administration of eldecalcitol (0, 7.5, 20, or 50&amp;nbsp;pmol) q.o.d. for 2&amp;nbsp;weeks dose-dependently
 increased ionized Ca, intestinal Ca absorption, and urinary Ca excretion, while these doses of calcitriol had no significant
 effects. The highest dose of eldecalcitol did not alter serum Pi but stimulated both intestinal Pi absorption and urinary
 Pi excretion; the latter was attributable, in part, to increased ser...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5240822</comments>
            <pubDate>Mon, 12 Sep 2011 15:50:55 +0100</pubDate>
            <guid isPermaLink="false">5240822</guid>        </item>
        <item>
            <title>Hypophosphatemia Related to Paraneoplastic Cushing Syndrome in Prostate Cancer: Cure After Bilateral Adrenalectomy</title>
            <link>http://www.medworm.com/index.php?rid=5212415&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F322014jx73181330%2F</link>
            <description>We report the case of a 71-year-old man with progressive metastatic prostate cancer in whom simultaneous occurrence of paraneoplastic
 Cushing syndrome (CS) and tumor-induced osteomalacia (TIO) initially was suspected. However, the evolution of biochemical
 markers of phosphate metabolism during disease course and after bilateral adrenalectomy argued against the diagnosis of TIO.
 Despite the persistence of progressive prostate cancer, CS and hypophosphatemia resolved in parallel after bilateral adrenalectomy.
 Thus, these data suggest that paraneoplastic CS per se was involved in the pathogenesis of hypophosphatemia. Calcitriol and
 intact fibroblast growth factor 23 (FGF23) levels were within the reference range at onset, which is inappropriate in the
 setting of severe hypophosphatemia....</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5212415</comments>
            <pubDate>Sat, 10 Sep 2011 15:49:01 +0100</pubDate>
            <guid isPermaLink="false">5212415</guid>        </item>
        <item>
            <title>Ultrastructural and Mineral Phase Characterization of the Bone-Like Matrix Assembled in F-OST Osteoblast Cultures</title>
            <link>http://www.medworm.com/index.php?rid=5212416&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa17122365h701r74%2F</link>
            <description>In conclusion, F-OST osteoblast cultures produce a bone-like matrix
 and may provide a good model for bone mineralization studies.
 
 
	Content Type Journal ArticleCategory Original ResearchPages 1-14DOI 10.1007/s00223-011-9526-9Authors
		W. Querido, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, BrazilL. G. Abraçado, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, BrazilA. L. Rossi, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, BrazilA. P. C. Campos, Divisão de Metrologia de Materiais, Instituto Nacional de Metrologia, Normalização e Qualidade Industrial, Duque de Caxias, RJ 25250-020, BrazilA. M. Rossi, Grupo ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5212416</comments>
            <pubDate>Thu, 08 Sep 2011 06:05:30 +0100</pubDate>
            <guid isPermaLink="false">5212416</guid>        </item>
        <item>
            <title>Blood Vessel Wall–Derived Endothelial Colony-Forming Cells Enhance Fracture Repair and Bone Regeneration</title>
            <link>http://www.medworm.com/index.php?rid=5193020&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb74423522g00p513%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Endochondral bone formation requires new blood vessel formation, and endothelial progenitor cells (EPCs) may play a role in
 this process. Endothelial colony-forming cells (ECFCs), one subtype of EPCs, isolated from the microvasculature of rat lungs,
 exhibited cell surface antigen markers and gene products characteristic of endothelial cells and displayed high proliferative
 potential and an ability to form vessel-like network structures in vitro. The aim of this study was to evaluate whether ECFCs
 facilitate bone healing during fracture repair and stimulate bone regeneration. When type I collagen sponge containing ECFCs
 were surgically wrapped around the fractured femurs of rats, newly formed bone mineral at the site of fracture was 13% greater
 (P&amp;nbsp;=&amp;nbsp;0.01)...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5193020</comments>
            <pubDate>Thu, 01 Sep 2011 06:11:15 +0100</pubDate>
            <guid isPermaLink="false">5193020</guid>        </item>
        <item>
            <title>The Combination of Structural Parameters and Areal Bone Mineral Density Improves Relation to Proximal Femur Strength: An In Vitro Study with High-Resolution Peripheral Quantitative Computed Tomography</title>
            <link>http://www.medworm.com/index.php?rid=5171537&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg76171l044128050%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this study was to assess structural indices from high-resolution peripheral quantitative computed tomography (HR-pQCT)
 images of the human proximal femur along with areal bone mineral density (aBMD) and compare the relationship of these parameters
 to bone strength in vitro. Thirty-one human proximal femur specimens (8 men and 23 women, median age 74&amp;nbsp;years, range 50–89)
 were examined with HR-pQCT at four regions of interest (femoral head, neck, major and minor trochanter) with 82&amp;nbsp;μm and in
 a subgroup (n&amp;nbsp;=&amp;nbsp;17) with 41&amp;nbsp;μm resolution. Separate analyses of cortical and trabecular geometry, volumetric BMD (vBMD), and microarchitectural
 parameters were obtained. In addition, aBMD by dual-energy X-ray absorptiometry (DXA) was perform...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5171537</comments>
            <pubDate>Sat, 27 Aug 2011 15:48:09 +0100</pubDate>
            <guid isPermaLink="false">5171537</guid>        </item>
        <item>
            <title>Osteocyte Deficiency in Hip Fractures</title>
            <link>http://www.medworm.com/index.php?rid=5171538&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy5qln888968605m3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Osteocytes play a central role in the regulation of bone remodeling. The aim of this study was to explore osteocyte function,
 and particularly the expression of SOST, a Wnt inhibitor, in patients with hip fractures. Serum sclerostin levels were measured by ELISA. The expression of several
 osteocytic genes was studied by quantitative PCR in trabecular samples of the femoral head of patients with hip fractures,
 hip osteoarthritis and control subjects. The presence of sclerostin protein and activated caspase 3 was revealed by immunostaining.
 There were no significant differences in serum sclerostin between the three groups. Patients with fractures have fewer lacunae
 occupied by osteocytes (60&amp;nbsp;±&amp;nbsp;5% vs. 64&amp;nbsp;±&amp;nbsp;6% in control subjects, P&amp;nbsp;=&amp;nbsp;0....</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5171538</comments>
            <pubDate>Sat, 27 Aug 2011 15:48:08 +0100</pubDate>
            <guid isPermaLink="false">5171538</guid>        </item>
        <item>
            <title>Mechanical Loading Stimulates BMP7, But Not BMP2, Production by Osteocytes</title>
            <link>http://www.medworm.com/index.php?rid=5148759&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F011u06k2494q4k60%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Bone mechanical adaptation is a cellular process that allows bones to adapt their mass and structure to mechanical loading.
 This process is governed by the osteocytes, which in response to mechanical loading produce signaling molecules that affect
 osteoblasts and osteoclasts. Bone morphogenic proteins (BMPs) are excellent candidates as signaling molecules, but it is unknown
 whether mechanically stimulated osteocytes affect bone adaptation through BMP production. Therefore, the aim of this study
 was to assess whether osteocytes produce BMPs in response to mechanical loading. In addition, since BMP7 has a vitamin D receptor
 (VDR) response element in the promoter region, we also investigated whether VDR is involved in the BMP7 response to mechanical
 loading. Human or...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5148759</comments>
            <pubDate>Sat, 13 Aug 2011 06:06:13 +0100</pubDate>
            <guid isPermaLink="false">5148759</guid>        </item>
        <item>
            <title>Longitudinal Changes of Bone Ultrasound Measurements in Healthy Infants during the First Year of Life: Influence of Gender and Type of Feeding</title>
            <link>http://www.medworm.com/index.php?rid=5112215&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk316208806554700%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There is evidence suggesting that early events in life may predispose the adult to osteoporosis. We assessed bone status by
 quantitative ultrasonography in healthy neonates, and we report the changes occurring during the first year of life, according
 to the type of early feeding. We measured the speed of sound (SOS) of the left tibia in 116 full-term infants (0–9&amp;nbsp;days of
 age) and in their mothers (21–42&amp;nbsp;years of age). SOS values did not correlate with gestational age of the study subjects (r&amp;nbsp;=&amp;nbsp;0.08) or anthropometric measurements. The SOS measurements of the mothers did not correlate with those of their children
 (r&amp;nbsp;=&amp;nbsp;0.01). Fifty-seven infants had SOS measurements performed at 4 and 12&amp;nbsp;months. Twenty-five infants were exclusive...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5112215</comments>
            <pubDate>Sun, 07 Aug 2011 05:52:34 +0100</pubDate>
            <guid isPermaLink="false">5112215</guid>        </item>
        <item>
            <title>Poor Trabecular Microarchitecture in Male Current Smokers: The Cross-Sectional STRAMBO Study</title>
            <link>http://www.medworm.com/index.php?rid=5081914&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe27100x8672g457w%2F</link>
            <description>In conclusion, older men who are moderate current smokers have poor trabecular
 (but not cortical) microarchitecture, which is not reflected by a decrease in aBMD.
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s00223-011-9519-8Authors
		P. Szulc, INSERM Research Unit 1033, Hôpital Edouard Herriot, Université de Lyon, Place d’Arsonval, 69437 Lyon, FranceE. Debiesse, INSERM Research Unit 1033, Hôpital Edouard Herriot, Université de Lyon, Place d’Arsonval, 69437 Lyon, FranceS. Boutroy, INSERM Research Unit 1033, Hôpital Edouard Herriot, Université de Lyon, Place d’Arsonval, 69437 Lyon, FranceN. Vilauphiou, INSERM Research Unit 1033, Hôpital Edouard Herriot, Université de Lyon, Place d’Arsonval, 69437 Lyon, FranceR. Chapurlat, INSERM Research Unit 1033, Hôpital Edouard...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5081914</comments>
            <pubDate>Thu, 28 Jul 2011 15:59:39 +0100</pubDate>
            <guid isPermaLink="false">5081914</guid>        </item>
        <item>
            <title>Association between DHEAS and Bone Loss in Postmenopausal Women: A 15-Year Longitudinal Population-Based Study</title>
            <link>http://www.medworm.com/index.php?rid=5081915&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn5316623m8112267%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Our aim was to examine the association between serum dehydroepiandrosterone sulfate (DHEAS) at baseline and BMD change at
 the femoral neck (FN) and lumbar spine (LS) in postmenopausal women during a 15-year follow-up. All participants were from
 the Chingford Study. BMD at the FN and LS were measured eight times during the 15-year follow-up by dual-energy X-ray absorptiometry.
 DHEAS at baseline was measured using radioimmunoassay. Data on height, weight, and hormone-replacement therapy (HRT) status
 were obtained at each visit. Multilevel linear regression modeling was used to examine the association between longitudinal
 BMD change at the FN and LS and DHEAS at baseline. Postmenopausal women (n&amp;nbsp;=&amp;nbsp;1,003) aged 45–68&amp;nbsp;years (mean 54.7) at baseline were i...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5081915</comments>
            <pubDate>Tue, 26 Jul 2011 05:51:27 +0100</pubDate>
            <guid isPermaLink="false">5081915</guid>        </item>
        <item>
            <title>Forearm Bone Mineral Density in Familial Hypocalciuric Hypercalcemia and Primary Hyperparathyroidism: A Comparative Study</title>
            <link>http://www.medworm.com/index.php?rid=5058621&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmq076h48877l7798%2F</link>
            <description>The objective of this study was to compare total and regional forearm
 bone mineral density (BMD) in patients with PHPT and FHH and to examine if differences can be used to separate the two disorders.
 We included 63 FHH, and 121 PHPT patients in a cross-sectional study. We performed dual-energy X-ray absorptiometry scans
 of the forearm, hip and lumbar spine and measured a number of biochemical variables. PTH patients had significantly lower
 Z-scores in all parts of the forearm compared to FHH. This was also the case after adjustment for body mass index. When stratifying
 for age, gender and PTH, T-scores were still significantly lower in PHPT patients than in FHH patients at the total, the mid and the ultradistal forearm,
 but not at the proximal 1/3 forearm. In a multiple regression an...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5058621</comments>
            <pubDate>Fri, 22 Jul 2011 17:04:13 +0100</pubDate>
            <guid isPermaLink="false">5058621</guid>        </item>
        <item>
            <title>Gene Expression Profile of Steroid-induced Necrosis of Femoral Head of Rats</title>
            <link>http://www.medworm.com/index.php?rid=5058622&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn3k444lq82156462%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The key to treating steroid-induced necrosis of femoral heads (SINFH) is early diagnosis. Dramatic improvements in diagnosis
 could be made if the pathogenesis of SINFH was more fully understood; however, the underlying mechanism of this disease is
 currently unknown. To explore the potential mechanism of SINFH, we performed gene array analysis on a rat model of the disease
 and compare the expression profile with that of normal rats. A quantitative RT-PCR and immunohistochemistry (IHC) assays were
 used to confirm the microarray results. Compared to the control group, 190 genes in the experimental group were differentially
 expressed, with 52 up-regulated and 138 down-regulated. Of these genes, 102 are known (deposited in GenBank), while 88 of
 them are unknown. The kn...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5058622</comments>
            <pubDate>Thu, 21 Jul 2011 17:55:45 +0100</pubDate>
            <guid isPermaLink="false">5058622</guid>        </item>
        <item>
            <title>Familial Paget Disease and SQSTM1 Mutations in New Zealand</title>
            <link>http://www.medworm.com/index.php?rid=5012618&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0r2vn16865538195%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Genetic factors play an important role in the pathogenesis of Paget disease of bone (PDB). SQSTM1 is the most important disease-associated gene identified to date. We investigated the relationship of family history, phenotype,
 and SQSTM1 mutation status in New Zealand (a country with a high prevalence of PDB) in patients with a family history and/or a severe
 phenotype. We studied 61 unrelated subjects with familial PDB. Family history was subclassified into three groups according
 to the closeness of the relationship. We also studied a fourth group of 19 unrelated patients defined by early onset and/or
 severe disease but no family history. The PDB phenotype was defined according to age, alkaline phosphatase activity, and disease
 extent on scintiscan at the time of d...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5012618</comments>
            <pubDate>Thu, 07 Jul 2011 05:43:28 +0100</pubDate>
            <guid isPermaLink="false">5012618</guid>        </item>
        <item>
            <title>Risk of Newly Diagnosed Type 2 Diabetes Is Reduced in Users of Alendronate</title>
            <link>http://www.medworm.com/index.php?rid=4987989&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnu8065728727386l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To study the risk of developing type 1 (T1D) or type 2 (T2D) diabetes among users of drugs against osteoporosis compared to
 nonusers. Nationwide cohort study in Denmark with all users of drugs against osteoporosis (n&amp;nbsp;=&amp;nbsp;103,562) as exposed and three age- and sex-matched nondiabetic control subjects (n&amp;nbsp;=&amp;nbsp;310,683) randomly selected from the background population. The main outcome variable was an incident diagnosis of diabetes
 after the baseline date. Among users of alendronate, etidronate, and raloxifene, no change in the risk of T1D was observed.
 However, the risk of developing T2D was reduced with all three drugs (alendronate: hazard ratio [HR]&amp;nbsp;=&amp;nbsp;0.71, 95% confidence
 interval [CI] 0.59–0.85, etidronate: HR&amp;nbsp;=&amp;nbsp;0.77, 95% CI 0.69...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4987989</comments>
            <pubDate>Tue, 28 Jun 2011 06:05:53 +0100</pubDate>
            <guid isPermaLink="false">4987989</guid>        </item>
        <item>
            <title>Metabolic Changes Following 500 μg Monthly Administration of Calcidiol: A Study in Normal Females</title>
            <link>http://www.medworm.com/index.php?rid=4971911&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb644w52030075452%2F</link>
            <description>This study was performed to investigate the effect of monthly oral administration of 500&amp;nbsp;μg of calcidiol (25-hydroxyvitamin
 D3) for 4&amp;nbsp;months on both serum vitamin D levels and sequential changes of parameters of calcium metabolism; 18 normal women
 aged 24–72&amp;nbsp;years were investigated. There was a significant increase of serum 25(OH)D after the first administration; thereafter
 all values persisted significantly higher compared to the basal value (P&amp;nbsp;&amp;lt;&amp;nbsp;0.001). Mean 1,25(OH)2D serum levels peaked at day 3 and then tended to stabilize following day 30. During the first month, all mean values observed
 following the initial administration were significantly higher than basal values. The first calcidiol dose produced a significant
 reduction of serum PTH levels (P&amp;...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971911</comments>
            <pubDate>Fri, 24 Jun 2011 05:44:14 +0100</pubDate>
            <guid isPermaLink="false">4971911</guid>        </item>
        <item>
            <title>Experimental Stimulation of Bone Healing with Teriparatide: Histomorphometric and Microhardness Analysis in a Mouse Model of Closed Fracture</title>
            <link>http://www.medworm.com/index.php?rid=4971912&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj2267416m303457l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Fracture consolidation is a crucial goal to achieve as early as possible, but pharmacological stimulation has been neglected
 so far. Teriparatide has been considered for this purpose for its anabolic properties. We set up a murine model of closed
 tibial fracture on which different doses of teriparatide were tested. Closed fracture treatment avoids any bias introduced
 by surgical manipulations. Teriparatide’s effect on callus formation was monitored during the first 4&amp;nbsp;weeks from fracture.
 Callus evolution was determined by histomorphometric and microhardness assessment. Daily administration of 40&amp;nbsp;μg/kg of teriparatide
 accelerated callus mineralization from day 9 onward without significant increase of sizes, and at day 15 the microhardness
 properties of...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971912</comments>
            <pubDate>Fri, 24 Jun 2011 05:44:12 +0100</pubDate>
            <guid isPermaLink="false">4971912</guid>        </item>
        <item>
            <title>MKP-1 Knockout Does not Prevent Glucocorticoid-Induced Bone Disease in Mice</title>
            <link>http://www.medworm.com/index.php?rid=4971913&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu155u800018x842l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Glucocorticoid-induced osteoporosis (GCOP) is predominantly caused by inhibition of bone formation, resulting from a decrease
 in osteoblast numbers. Employing mouse (MBA-15.4) and human (MG-63) osteoblast cell lines, we previously found that the glucocorticoid
 (GC) dexamethasone (Dex) inhibits cellular proliferation as well as activation of the MAPK/ERK signaling pathway, essential
 for mitogenesis in these cells, and that both these effects could be reversed by the protein tyrosine phosphatase (PTP) inhibitor
 vanadate. In a rat model of GCOP, the GC-induced changes in bone formation, mass, and strength could be prevented by vanadate
 cotreatment, suggesting that the GC effects on bone were mediated by one or more PTPs. Employing phosphatase inhibitors, qRT-PCR,
 Wes...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971913</comments>
            <pubDate>Thu, 23 Jun 2011 06:02:04 +0100</pubDate>
            <guid isPermaLink="false">4971913</guid>        </item>
        <item>
            <title>Bone Mineral Density in Young Women on Methadone Substitution</title>
            <link>http://www.medworm.com/index.php?rid=4963443&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp04737g5p4623437%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Little is known about bone mineral density (BMD) in patients with heroin addiction and subsequent methadone substitution.
 The goal of this study was to compare bone mass density of young HIV-negative women on long-term methadone treatment to a
 local group of young healthy women. Eleven women (aged 20–29) with previous heroin dependence and current methadone substitution
 (20–140&amp;nbsp;mg, median 60, daily) for 1.5–9 (median 3) years were compared to 30 healthy women (aged 20–28). Participants were
 examined with dual-energy X-ray absorptiometry of the lumbar spine (L2–L4), of the total proximal hip area, and of the femoral
 neck. Patients and controls had neither current nor lifetime underweight condition, had comparable ages at menarche, and did
 not differ ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4963443</comments>
            <pubDate>Wed, 22 Jun 2011 15:59:16 +0100</pubDate>
            <guid isPermaLink="false">4963443</guid>        </item>
        <item>
            <title>Can 11β-Hydroxysteroid Dehydrogenase Activity Predict the Sensitivity of Bone to Therapeutic Glucocorticoids in Inflammatory Bowel Disease?</title>
            <link>http://www.medworm.com/index.php?rid=4963445&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg585453p84t32612%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In healthy individuals measures of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme activity predict the change in
 bone formation markers in response to therapeutic glucocorticoids. It is unclear whether these measures remain predictive
 in inflammatory disease. We therefore examined whether 11β-HSD1 activity predicts changes in bone markers and bone mineral
 density (BMD) in patients with inflammatory bowel disease (IBD) treated with therapeutic glucocorticoids. Prospective and
 cross-sectional studies were carried out in patients attending a gastroenterology clinic with active (n&amp;nbsp;=&amp;nbsp;39) or clinically inactive (n&amp;nbsp;=&amp;nbsp;34) IBD and healthy controls (n&amp;nbsp;=&amp;nbsp;51). Urinary corticosteroid metabolite profiles were obtained on a spot urine sa...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4963445</comments>
            <pubDate>Wed, 22 Jun 2011 06:07:20 +0100</pubDate>
            <guid isPermaLink="false">4963445</guid>        </item>
        <item>
            <title>Gastrointestinal Tolerability and Patterns of Switching in Patients Treated for Primary Osteoporosis: The Swedish Adherence Register Analysis (SARA)</title>
            <link>http://www.medworm.com/index.php?rid=4963444&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1p812g8782722558%2F</link>
            <description>In conclusion,
 no significant difference in the incidence of GIAEs was found between patients prescribed alendronate, risedronate, and strontium
 ranelate. Individuals prescribed raloxifene had a significantly lower risk of GIAEs compared with patients prescribed alendronate.
 No significant difference was found in the frequency of hospitalization for GIAEs. Switching between osteoporosis medications
 and drug classes was uncommon. Prescribers should consider the real-world gastrointestinal safety of osteoporosis drugs when
 choosing between treatment options to potentially improve medication adherence and consequently effectiveness.
 
 
	Content Type Journal ArticlePages 1-12DOI 10.1007/s00223-011-9511-3Authors
		Erik Landfeldt, Innovus, Stockholm, SwedenAndrea Lang, Innovus, Stockholm, ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4963444</comments>
            <pubDate>Wed, 22 Jun 2011 06:07:20 +0100</pubDate>
            <guid isPermaLink="false">4963444</guid>        </item>
        <item>
            <title>The Oncofetal Gene Survivin Promotes Cell Proliferation and Survival in Primary Human Osteoblastic Cells</title>
            <link>http://www.medworm.com/index.php?rid=4947906&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft4647x65j523081x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Survivin, the smallest member of the inhibitor of apoptosis gene family, is critical for the regulation of mitosis and maintenance
 of cell viability during embryonic development and cancer, while not being detectable in most adult differentiated tissues.
 We know little about whether survivin plays any physiological or pathophysiological role in the adult musculoskeletal system.
 We studied the expression of survivin in primary human osteoblastic cells and its biological functions in vitro. Survivin
 was detected by immunoblotting and real-time PCR. Subcellular localization was analyzed by immunofluorescence. Transfection
 of siRNA and plasmids coding for wild-type survivin was performed to study survivin function, i.e., proliferation and apoptosis
 assays. Survivin mR...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4947906</comments>
            <pubDate>Wed, 15 Jun 2011 05:51:44 +0100</pubDate>
            <guid isPermaLink="false">4947906</guid>        </item>
        <item>
            <title>Do Both Areal BMD and Injurious Falls Explain the Higher Incidence of Fractures in Women than in Men?</title>
            <link>http://www.medworm.com/index.php?rid=4940368&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F350011u325n48574%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The higher incidence of fractures in women than in men is generally attributed to the lower areal bone mineral density (areal
 BMD, g/cm2) of the former. The purpose of the present study was to investigate both areal BMD and injurious falls as risk factors for
 fractures. In a first cohort, areal BMD was measured in 5,131 men and women (age range 40–95&amp;nbsp;years). In a second cohort, consisting
 of 26,565 men and women (age range 40–69&amp;nbsp;years), a health survey was conducted including questions about lifestyle and medication.
 Main outcome measures included validated prospective injurious falls and fractures in both cohorts. The higher areal BMD and
 femoral neck BMD in men compared to women (P&amp;nbsp;&amp;lt;&amp;nbsp;0.001) were explained by a higher diameter of the fem...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4940368</comments>
            <pubDate>Sat, 11 Jun 2011 06:02:51 +0100</pubDate>
            <guid isPermaLink="false">4940368</guid>        </item>
        <item>
            <title>DHEA Administration Activates Local Bioactive Androgen Metabolism in Cancellous Site of Tibia of Ovariectomized Rats</title>
            <link>http://www.medworm.com/index.php?rid=4915984&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjk7751w147825481%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It is not known whether local androgen metabolism is involved in the mechanisms underlying the dehydroepiandrosterone (DHEA)
 administration-induced improvement of bone mineral density (BMD) in an estrogen-deficiency state. The aim of the present study
 was to clarify whether DHEA administration would improve local androgen metabolism and BMD in cancellous site of tibia of
 ovariectomized (OVX) rats. Twenty-two female rats, 6&amp;nbsp;weeks old, were randomized into three groups: sham-operated rats, OVX
 control rats, and OVX rats that received DHEA treatment. DHEA was administered intraperitoneally at 20&amp;nbsp;mg/kg body weight for
 8&amp;nbsp;weeks. The concentrations of free testosterone and dihydrotestosterone (DHT) in cancellous site of tibia did not change
 as a result of ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915984</comments>
            <pubDate>Tue, 07 Jun 2011 15:52:29 +0100</pubDate>
            <guid isPermaLink="false">4915984</guid>        </item>
        <item>
            <title>Clinical Risk Factors for Osteoporosis in Ireland and the UK: A Comparison of FRAX and QFractureScores</title>
            <link>http://www.medworm.com/index.php?rid=4915985&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh42319n786077416%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recently two algorithms have become available to estimate the 10-year probability of fracture in patients suspected to have
 osteoporosis on the basis of clinical risk factors: the FRAX algorithm and QFractureScores algorithm (QFracture). The aim
 of this study was to compare the performance of these algorithms in a study of fracture patients and controls recruited from
 six centers in the United Kingdom and Ireland. A total of 246 postmenopausal women aged 50–85&amp;nbsp;years who had recently suffered
 a low-trauma fracture were enrolled and their characteristics were compared with 338 female controls who had never suffered
 a fracture. Femoral bone mineral density was measured by dual-energy X-ray absorptiometry, and fracture risk was calculated
 using the FRAX and QFr...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915985</comments>
            <pubDate>Tue, 07 Jun 2011 05:46:25 +0100</pubDate>
            <guid isPermaLink="false">4915985</guid>        </item>
        <item>
            <title>An Atypical Degenerative Osteoarthropathy in Hyp Mice is Characterized by a Loss in the Mineralized Zone of Articular Cartilage</title>
            <link>http://www.medworm.com/index.php?rid=4915986&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm7210l7w1w6p21p3%2F</link>
            <description>We report that, despite highly
 elevated levels of alkaline phosphatase activity throughout articular cartilage, there is a complete loss in the mineralized
 zone of articular cartilage as assessed by von Kossa staining of mineral and as quantified by EPIC-microCT analysis and evidence
 of vascular invasion. We also identify the downregulation of extracellular matrix (ECM) factors identified as regulators of
 terminally differentiated mineralizing articular chondrocytes. There is also a striking increase in the histochemical staining
 of sulfated proteoglycans, a change that may reflect the loss of a transitional tissue that reduces mechanical stress at the
 interface between cartilage and subchondral bone. The failure of mineralizing articular chondrocytes to develop in the hypophosphatem...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915986</comments>
            <pubDate>Sat, 04 Jun 2011 05:50:45 +0100</pubDate>
            <guid isPermaLink="false">4915986</guid>        </item>
        <item>
            <title>Incisor Enamel Formation is Impaired in Transgenic Rats Overexpressing the Type III NaPi Transporter Slc20a1</title>
            <link>http://www.medworm.com/index.php?rid=4915987&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl1433uk62v67gt57%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Inorganic phosphate (Pi) is required in many biological processes, including signaling cascades, skeletal development, tooth
 mineralization, and nucleic acid synthesis. Recently, we showed that Pi transport in osteoblasts, mediated by Slc20a1, a member
 of the type III sodium-dependent phosphate transporter family, is indispensable for osteoid mineralization in rapidly growing
 rat bone. In addition, we found that bone mineral density decreased slightly with dysfunction of Pi homeostasis in aged transgenic
 rats overexpressing mouse Slc20a1 (Slc20a1-Tg). Bone and tooth share certain common molecular features, and thus, we focused on tooth development in Slc20a1-Tg
 mandibular incisors in order to determine the role of Slc20a1 in tooth mineralization. Around the time of...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915987</comments>
            <pubDate>Sat, 04 Jun 2011 05:50:44 +0100</pubDate>
            <guid isPermaLink="false">4915987</guid>        </item>
        <item>
            <title>Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=4897381&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp41548q80r436300%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The pharmacological management of disease should involve consideration of the balance between the beneficial effects of treatment
 on outcome and the probability of adverse effects. The aim of this review is to explore the risk of adverse drug reactions
 and drug–drug interactions with treatments for postmenopausal osteoporosis. We reviewed evidence for adverse reactions from
 regulatory documents, randomized controlled trials, pharmacovigilance surveys, and case series. Bisphosphonates are associated
 with gastrointestinal effects, musculoskeletal pain, and acute-phase reactions, as well as, very rarely, atrial fibrillation,
 atypical fracture, delayed fracture healing, osteonecrosis of the jaw, hypersensitivity reactions, and renal impairment. Cutaneous
 effects and...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4897381</comments>
            <pubDate>Fri, 03 Jun 2011 05:58:10 +0100</pubDate>
            <guid isPermaLink="false">4897381</guid>        </item>
        <item>
            <title>VDR Haploinsufficiency Impacts Body Composition and Skeletal Acquisition in a Gender-Specific Manner</title>
            <link>http://www.medworm.com/index.php?rid=4897380&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyg35j5r3546x7908%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The vitamin D receptor (VDR) is crucial for virtually all of vitamin D’s actions and is thought to be ubiquitously expressed.
 We hypothesized that disruption of one allele of the VDR gene would impact bone development and would have metabolic consequences.
 Body composition and bone mass (BMD) in VDR heterozygous (VDR HET) mice were compared to those obtained in male and female
 VDR KO and WT mice at 8&amp;nbsp;weeks of age. Male mice were also evaluated at 16&amp;nbsp;weeks, and bone marrow mesenchymal stem cell (MSC)
 differentiation was evaluated in VDR female mice. Additionally, female VDR HET and WT mice received intermittent PTH treatment
 or vehicle (VH) for 4&amp;nbsp;weeks. BMD was determined at baseline and after treatment. MRI was done in vivo at the end of treatment;...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4897380</comments>
            <pubDate>Fri, 03 Jun 2011 05:58:10 +0100</pubDate>
            <guid isPermaLink="false">4897380</guid>        </item>
        <item>
            <title>Fibroblast Growth Factor 23 (FGF23) and Alpha-Klotho Stimulate Osteoblastic MC3T3.E1 Cell Proliferation and Inhibit Mineralization</title>
            <link>http://www.medworm.com/index.php?rid=4897382&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyx8315t1q7713010%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Elevated serum levels of the phosphate-regulating hormone fibroblast growth factor 23 (FGF23) are found in patients with phosphate
 wasting diseases and chronic kidney disease-mineral and bone disorder (CKD-MBD). These diseases are associated with rickets
 and renal osteodystrophy, respectively. FGF23 is secreted from osteoblastic cells and signals through FGFRs, membrane coreceptor
 alpha-Klotho (Klotho), and, possibly, a circulating form of Klotho. Despite the absence of detectable Klotho on osteoblastic
 cells, studies have suggested that forced FGF23 expression in osteoblasts inhibited mineralization. Thus, we examined the
 effects of exogenously applied FGF23 on osteoblastic MC3T3.E1 cell proliferation and differentiation, with and without soluble
 Klotho. MC3T3.E1...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4897382</comments>
            <pubDate>Thu, 02 Jun 2011 06:06:44 +0100</pubDate>
            <guid isPermaLink="false">4897382</guid>        </item>
        <item>
            <title>Teriparatide in Bisphosphonate-Resistant Osteoporosis: Microarchitectural Changes and Clinical Results After 6 and 18 months</title>
            <link>http://www.medworm.com/index.php?rid=4897383&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft6702417778053l2%2F</link>
            <description>The objective of this 18-month prospective study was to investigate the effect of teriparatide [rhPTH(1–34)]
 in 25 female osteoporotics who were inadequate responders to oral bisphosphonates and to correlate microarchitectural changes
 in three consecutive iliac crest biopsies measured by micro-computed tomography (μCT) with bone mineral density (BMD) and
 bone serum markers. Scanned biopsies at baseline (M0), 6&amp;nbsp;months (M6), and 18&amp;nbsp;months (M18) demonstrated early significant (P&amp;nbsp;&amp;lt;&amp;nbsp;0.01) increases in bone volume per tissue volume (+34%) and trabecular number (+14%) at M6 with only moderate changes in
 most μCT structural parameters between M6 and M18. μCT-measured bone tissue density was significantly decreased at M18, expressing
 an overall lower degree of tissu...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4897383</comments>
            <pubDate>Fri, 27 May 2011 18:12:03 +0100</pubDate>
            <guid isPermaLink="false">4897383</guid>        </item>
        <item>
            <title>IL-12- and IL-18-Mediated, Nitric Oxide-Induced Apoptosis in TNF-α-Mediated Osteoclastogenesis of Bone Marrow Cells</title>
            <link>http://www.medworm.com/index.php?rid=4897384&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F53508401r3x02775%2F</link>
            <description>In this study, we examined whether NO causes the IL-12- and
 IL-18-induced apoptosis of bone marrow cells in TNF-α-mediated osteoclast formation. We found that NO production was induced
 in bone marrow cells cultured with IL-12 and IL-18 in the presence of TNF-α. When bone marrow cells were cultured with TNF-α,
 osteoclasts were formed. In contrast, when bone marrow cells were cultured with both TNF-α and IL-12 or IL-18, the adherent
 cells were induced to undergo apoptosis. Apoptosis was partially inhibited when bone marrow cells were treated with NO synthase
 inhibitors. Furthermore, IL-12 and IL-18 synergistically induced cell death and upregulated NO production in the presence
 of TNF-α. These results indicate that the simultaneous effects of TNF-α and IL-12 or IL-18 on bone marr...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4897384</comments>
            <pubDate>Tue, 24 May 2011 16:04:19 +0100</pubDate>
            <guid isPermaLink="false">4897384</guid>        </item>
        <item>
            <title>Nmp4/CIZ Suppresses the Response of Bone to Anabolic Parathyroid Hormone by Regulating Both Osteoblasts and Osteoclasts</title>
            <link>http://www.medworm.com/index.php?rid=4897385&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd78x13764314jp16%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;How parathyroid hormone (PTH) increases bone mass is unclear, but understanding this phenomenon is significant to the improvement
 of osteoporosis therapy. Nmp4/CIZ is a nucleocytoplasmic shuttling transcriptional repressor that suppresses PTH-induced osteoblast
 gene expression and hormone-stimulated gains in murine femoral trabecular bone. To further characterize Nmp4/CIZ suppression
 of hormone-mediated bone growth, we treated 10-week-old Nmp4-knockout (KO) and wild-type (WT) mice with intermittent human PTH(1–34) at 30&amp;nbsp;μg/kg daily or vehicle, 7&amp;nbsp;days/week, for 2,
 3, or 7&amp;nbsp;weeks. Null mice treated with hormone (7&amp;nbsp;weeks) gained more vertebral and tibial cancellous bone than WT animals,
 paralleling the exaggerated response in the femur. Interesti...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4897385</comments>
            <pubDate>Tue, 24 May 2011 05:53:44 +0100</pubDate>
            <guid isPermaLink="false">4897385</guid>        </item>
        <item>
            <title>Measuring Differences in Compositional Properties of Bone Tissue by Confocal Raman Spectroscopy</title>
            <link>http://www.medworm.com/index.php?rid=4849232&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp138h81102109902%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The full range of fracture risk determinants arise from each hierarchical level comprising the organization of bone. Raman
 spectroscopy is one tool capable of characterizing the collagen and mineral phases at a near submicron-length scale, but the
 ability of Raman spectra to distinguish compositional differences of bone is not well defined. Therefore, we analyzed multiple
 Raman peak intensities and peak ratios to characterize their ability to distinguish between the typically less mineralized
 osteonal tissue and the more mineralized interstitial tissue in intracortical human bone. To further assess origins of variance,
 we collected Raman spectra from embedded specimens and for two orientations of cut. Per specimen, Raman peak intensities or
 ratios were averaged am...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4849232</comments>
            <pubDate>Thu, 19 May 2011 16:33:44 +0100</pubDate>
            <guid isPermaLink="false">4849232</guid>        </item>
        <item>
            <title>Sex Differences in Chondrocyte Maturation in the Mandibular Condyle from a Decreased Occlusal Loading Model</title>
            <link>http://www.medworm.com/index.php?rid=4849233&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7853454u17211j87%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Temporomandibular joint disorders (TMDs) predominantly afflict women of childbearing age. Defects in mechanical loading-induced
 temporomandibular joint (TMJ) remodeling are believed to be a major etiological factor in the development of TMD. The goal
 of this study was to determine if there are sex differences in CD-1 and C57BL/6 mice exposed to a decreased occlusal loading
 TMJ remodeling model. Male and female CD-1 and C57BL/6 mice, 21&amp;nbsp;days old, were each divided into two groups. They were fed
 either a normal pellet diet (normal loading) or a soft diet and had their incisors trimmed out of occlusion (decreased occlusal
 loading) for 4&amp;nbsp;weeks. The mandibular condylar cartilage was evaluated by histology, and the subchondral bone was evaluated
 by micro-CT an...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4849233</comments>
            <pubDate>Thu, 19 May 2011 16:33:43 +0100</pubDate>
            <guid isPermaLink="false">4849233</guid>        </item>
        <item>
            <title>Maxillary Sinus Floor Elevation Using BMP-2 and Nell-1 Gene-Modified Bone Marrow Stromal Cells and TCP in Rabbits</title>
            <link>http://www.medworm.com/index.php?rid=4834590&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr6g02115m50h3104%2F</link>
            <description>This study evaluated the synergistic osteogenic effect of bone morphogenetic protein-2 (BMP-2) and Nel-like molecule-1 (Nell-1)
 genes in a rabbit maxillary sinus floor elevation model. Bone marrow stromal cells (bMSCs) were cultured and transduced with
 AdEGFP, AdNell-1, AdBMP-2, or AdNell-1&amp;nbsp;+&amp;nbsp;AdBMP-2 overexpression virus. These gene-modified autologous bMSCs were then combined
 with a β-tricalcium phosphate (β-TCP) granule scaffold and used to elevate the maxillary sinus floor in rabbits. bMSCs cotransduced
 with AdNell-1&amp;nbsp;+&amp;nbsp;AdBMP-2 demonstrated a synergistic effect on osteogenic differentiation as detected by real-time PCR analysis
 on markers of runt-related transcription factor-2, osteocalcin, collagen type 1, alkaline phosphatase activity, and calcium
 deposits i...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4834590</comments>
            <pubDate>Mon, 16 May 2011 08:42:24 +0100</pubDate>
            <guid isPermaLink="false">4834590</guid>        </item>
        <item>
            <title>Long-Term Effects of Neridronate and its Discontinuation in Patients with Primary Hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=4834591&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6145w6845t8275wm%2F</link>
            <description>In conclusion, in this study we observed that
 in patients with mild PHPT treatment with bisphosphonates is associated with the expected changes in bone-turnover markers
 and that the significant increases of both hip and spine BMD are partially maintained for at least 2&amp;nbsp;years after treatment
 discontinuation at the vertebral site. The marked increases in serum PTH levels, particularly in subjects with low 25OHD levels,
 persist after treatment discontinuation and this raises the suspicion that this might reflect a worsening of PHPT.
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s00223-011-9489-xAuthors
		Maurizio Rossini, Rheumatology Unit, Department of Medicine, University of Verona, OCM Borgo Trento, P.le Stefani 1, 37126 Verona, ItalyOmbretta Viapiana, Rheumatology Unit, ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4834591</comments>
            <pubDate>Thu, 12 May 2011 16:44:49 +0100</pubDate>
            <guid isPermaLink="false">4834591</guid>        </item>
        <item>
            <title>Three-Dimensional Evaluation of Mandibular Bone Regenerated By Bone Transport Distraction Osteogenesis</title>
            <link>http://www.medworm.com/index.php?rid=4816030&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd502u5370782426w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The purpose of this study was to evaluate the structure and material properties of native mandibular bone and those of early
 regenerate bone, produced by bone transport distraction osteogenesis. Ten adult foxhounds were divided into two groups of
 five animals each. In all animals, a 3- to 4-cm defect was created on one side of the mandible. A bone transport reconstruction
 plate, consisting of a reconstruction plate with an attached intraoral transport unit, was utilized to stabilize the mandible
 and regenerate bone at a rate of 1&amp;nbsp;mm/day. After the distraction period was finished, the animals were killed at 6 and 12&amp;nbsp;weeks
 of consolidation. Micro-computed tomography was used to assess the morphometric and structural indices of regenerate bone
 and matching ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4816030</comments>
            <pubDate>Tue, 10 May 2011 06:01:23 +0100</pubDate>
            <guid isPermaLink="false">4816030</guid>        </item>
        <item>
            <title>Calpain Modulates Cyclin-Dependent Kinase Inhibitor 1B (p27Kip1) in Cells of the Osteoblast Lineage</title>
            <link>http://www.medworm.com/index.php?rid=4791638&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7x50432002774023%2F</link>
            <description>In conclusion, calpain is a critical modulator for regulation of p27Kip1 in cells of the osteoblast lineage.
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s00223-011-9491-3Authors
		Aki Kashiwagi, Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Thier 10, 50 Blossom Street, Boston, MA 02114, USAMikaela J. Fein, Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Thier 10, 50 Blossom Street, Boston, MA 02114, USAMasako Shimada, Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Thier 10, 50 Blossom Street, Boston, MA 02114, USA
	

	
		Journal Calcified Tissue InternationalOnline ISSN 1432-0827Print ISSN 0171-967X (Source: Calcified Tissue Internatio...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4791638</comments>
            <pubDate>Wed, 04 May 2011 14:53:59 +0100</pubDate>
            <guid isPermaLink="false">4791638</guid>        </item>
        <item>
            <title>Cinacalcet HCl Suppresses Cyclin D1 Oncogene-Derived Parathyroid Cell Proliferation in a Murine Model for Primary Hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=4791639&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F01740127q623r55u%2F</link>
            <description>In this study, the effect of cinacalcet on parathyroid cell proliferation was analyzed in PHPT mice. Cinacalcet (1&amp;nbsp;mg/g) was
 mixed into the rodent diet and orally administrated to 80-week-old PHPT mice for 10&amp;nbsp;days before death. 5-Bromo-2′-deoxyuridine
 (BrdU, 6&amp;nbsp;mg/day) was infused by an osmotic pump for 5&amp;nbsp;days before death, followed by immunostaining of the thyroid–parathyroid
 complex using an anti-BrdU antibody to estimate parathyroid cell proliferation. Compared to untreated PHPT mice, cinacalcet
 significantly suppressed both serum calcium and PTH. The proportion of BrdU-positive cells to the total cell number in the
 parathyroid glands increased considerably in untreated PHPT mice (9.5&amp;nbsp;±&amp;nbsp;3.1%) compared to wild-type mice (0.7&amp;nbsp;±&amp;nbsp;0.1%) and
 ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4791639</comments>
            <pubDate>Tue, 03 May 2011 19:46:14 +0100</pubDate>
            <guid isPermaLink="false">4791639</guid>        </item>
        <item>
            <title>Early Growth Response Gene 1 Regulates Bone Properties in Mice</title>
            <link>http://www.medworm.com/index.php?rid=4784650&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx08710427026t724%2F</link>
            <description>This study provides genetic
 evidence that both sex and skeletal site are critical determinants of EGR-1 activity in vivo and that its site-specific action
 may contribute to the mechanical properties of bone.
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s00223-011-9486-0Authors
		Marie K. Reumann, Bone Cell Biology and Imaging Laboratory, Caspary Research Building, Rm. 623, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USAOlga Strachna, Bone Cell Biology and Imaging Laboratory, Caspary Research Building, Rm. 623, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USALyudmila Lukashova, Mineralized Tissue Laboratory, Hospital for Special Surgery, New York, USAKostas Verdelis, Mineralized Tissue Laboratory, Hospital for Special Surgery...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4784650</comments>
            <pubDate>Sun, 01 May 2011 15:32:05 +0100</pubDate>
            <guid isPermaLink="false">4784650</guid>        </item>
        <item>
            <title>Mineral Composition is Altered by Osteoblast Expression of an Engineered Gs-Coupled Receptor</title>
            <link>http://www.medworm.com/index.php?rid=4784651&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F25n61tkm364j3288%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Activation of the Gs G protein–coupled receptor Rs1 in osteoblasts increases bone mineral density by 5- to 15-fold in mice and recapitulates histologic
 aspects of fibrous dysplasia of the bone. However, the effects of constitutive Gs signaling on bone tissue quality are not known. The goal of this study was to determine bone tissue quality in mice resulting
 from osteoblast-specific constitutive Gs activation, by the complementary techniques of FTIR spectroscopy and synchrotron radiation micro-computed tomography (SRμCT).
 Col1(2.3)-tTA/TetO-Rs1 double transgenic (DT) mice, which showed osteoblast-specific constitutive Gs signaling activity by the Rs1 receptor, were created. Femora and calvariae of DT and wild-type (WT) mice (6 and 15&amp;nbsp;weeks
 old) were analyzed ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4784651</comments>
            <pubDate>Wed, 27 Apr 2011 10:55:33 +0100</pubDate>
            <guid isPermaLink="false">4784651</guid>        </item>
        <item>
            <title>Monthly Administration of a Novel PTH-Collagen Binding Domain Fusion Protein is Anabolic in Mice</title>
            <link>http://www.medworm.com/index.php?rid=4750005&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpv5t25735j0k283p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We synthesized fusion proteins of parathyroid hormone (PTH) (1–33) and the collagen binding domain of ColH (CBD) and tested
 them for anabolic bone activity in mice. Two fusion proteins were synthesized, linking the carboxy terminus of PTH(1–33) either
 directly to the amino terminal of the CBD or to the CBD through an adjacent ColH domain (PTH-PKD-CBD). Both PTH-CBD and PTH-PKD-CBD
 increased cAMP accumulation in cells stably transfected with the PTH/PTHrP receptor, and both peptides bound to type 1 collagen
 in flow-through assays. Distribution studies indicated that the PTH-CBD was concentrated in the bone and skin, tissues with
 abundant collagen and blood flow. Administration of 320&amp;nbsp;μg/kg PTH-CBD either weekly (for 8&amp;nbsp;weeks) or monthly (for 6&amp;nbsp;mon...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4750005</comments>
            <pubDate>Thu, 21 Apr 2011 18:00:36 +0100</pubDate>
            <guid isPermaLink="false">4750005</guid>        </item>
        <item>
            <title>Influence of Insulin-Like Growth Factor Binding Protein (IGFBP)-1 and IGFBP-3 on Bone Health: Results from the European Male Ageing Study</title>
            <link>http://www.medworm.com/index.php?rid=4745507&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff6628g7268320w56%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this study was to determine the influence of insulin-like growth factor binding protein (IGFBP)-1, IGFBP-3, and
 IGF-I on calcaneal ultrasound parameters in middle-aged and elderly European men. Men aged 40–79&amp;nbsp;years were recruited from
 population registers for participation in the European Male Ageing Study (EMAS). Subjects were invited by letter to complete
 a postal questionnaire and to attend for an interviewer-assisted questionnaire, quantitative ultrasound (QUS) of the calcaneus,
 and a fasting blood sample from which serum levels of IGFBP-1, IGFBP-3, IGF-I, estradiol (E2), and SHBG were assayed. The questionnaires included the Physical Activity Scale for the Elderly (PASE) and questions about
 smoking and alcohol consumption. Estimated bone mine...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4745507</comments>
            <pubDate>Tue, 19 Apr 2011 07:13:52 +0100</pubDate>
            <guid isPermaLink="false">4745507</guid>        </item>
        <item>
            <title>Nonenzymatic Cross-Linking Pentosidine Increase in Bone Collagen and Are Associated with Disorders of Bone Mineralization in Dialysis Patients</title>
            <link>http://www.medworm.com/index.php?rid=4745508&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk32045pm16811586%2F</link>
            <description>This study suggests that AGE collagen cross-links
 strongly associate with disorders of bone metabolism in dialysis patients.
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s00223-011-9488-yAuthors
		Jun Mitome, Division of Kidney and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, Tokyo, JapanHiroyasu Yamamoto, Division of Kidney and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, Tokyo, JapanMitsuru Saito, Department of Orthopedic Surgery, The Jikei University School of Medicine, Tokyo, JapanKeitaro Yokoyama, Division of Kidney and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4745508</comments>
            <pubDate>Sat, 16 Apr 2011 15:56:24 +0100</pubDate>
            <guid isPermaLink="false">4745508</guid>        </item>
        <item>
            <title>Randomized Trial of Alendronate Plus Vitamin D3 Versus Standard Care in Osteoporotic Postmenopausal Women with Vitamin D Insufficiency</title>
            <link>http://www.medworm.com/index.php?rid=4706215&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp5q3632332553402%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Vitamin D insufficiency is common in patients with osteoporosis. We conducted a randomized trial comparing alendronate 70&amp;nbsp;mg
 combined with vitamin D3 5,600&amp;nbsp;IU in a single tablet (ALN/D5600, n&amp;nbsp;=&amp;nbsp;257) with standard care chosen by the patients’ personal physicians (n&amp;nbsp;=&amp;nbsp;258) in patients with postmenopausal osteoporosis (BMD T score ≤2.5 or ≤1.5 and a prior fragility fracture) who had vitamin
 D insufficiency (serum 25[OH]D values 8–20&amp;nbsp;ng/ml) and who were at risk of falls. Virtually all patients randomized to standard
 care received bisphosphonate therapy, and in approximately 70% of cases this was combined with vitamin D supplements. However,
 only 24% took ≥800&amp;nbsp;IU/day of supplemental vitamin D. At 6&amp;nbsp;months the proport...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706215</comments>
            <pubDate>Sun, 10 Apr 2011 15:41:08 +0100</pubDate>
            <guid isPermaLink="false">4706215</guid>        </item>
        <item>
            <title>Sex Difference between Body Composition and Weight-Bearing Bone Mineral Density in Korean Adult Twins: Healthy Twin Study</title>
            <link>http://www.medworm.com/index.php?rid=4706216&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu146125144v5q25w%2F</link>
            <description>This study controlled for common genetic factors
 and applied only to environmental factors, using 185 MZ twin pairs aged 30–50&amp;nbsp;years (140 male subjects, 230 female subjects).
 As expected, total lean mass (TLM) was greater in males and total fat mass (TFM) was greater in females. In male twins, TLM
 was associated with BMD at the legs, pelvis, and spine, with percent BMD increases of 0.41 (95% confidence interval [CI] 0.17–0.64),
 0.62 (95% CI 0.35–0.89), and 0.27 (95% CI 0.01–0.54) for every 1&amp;nbsp;kg. In female twins, TFM was associated with BMD at the legs
 and pelvis, with percent BMD increases of 0.10 (95% CI 0.03–0.17) and 0.10 (95% CI 0.02–0.18) for every 1&amp;nbsp;kg. The results
 support the hypothesis that skeletal muscle and bone mass in middle-aged men are linked...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706216</comments>
            <pubDate>Fri, 08 Apr 2011 16:59:23 +0100</pubDate>
            <guid isPermaLink="false">4706216</guid>        </item>
        <item>
            <title>Use of Antidepressant Medications and Risk of Fracture in Older Women</title>
            <link>http://www.medworm.com/index.php?rid=4678697&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2g13056233167202%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Use of antidepressant medications has been associated with increased risk of fracture, but prior studies have been limited
 by incomplete control of confounders or a limited number of fractures. Use of antidepressant medications by 8,217 community-dwelling
 women aged 69 and older from a population-based prospective cohort study at four US clinical centers was assessed by interview
 at four examinations over a 10-year period, beginning in 1992–1994. Use was coded as a time-dependent variable. Incident fractures
 occurring after the initial medication assessment until July 2007 were confirmed by radiographic reports. Potential confounders
 were included in multivariable models and updated at each follow-up visit. Compared to nonusers of antidepressant medications,
 wom...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4678697</comments>
            <pubDate>Thu, 31 Mar 2011 17:40:38 +0100</pubDate>
            <guid isPermaLink="false">4678697</guid>        </item>
        <item>
            <title>Effects of Risedronate in Runx2 Overexpressing Mice, an Animal Model for Evaluation of Treatment Effects on Bone Quality and Fractures</title>
            <link>http://www.medworm.com/index.php?rid=4678696&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fau9008m255w73j21%2F</link>
            <description>In conclusion, young mice overexpressing Runx2
 have high bone turnover-induced osteopenia and spontaneous fractures. Ris at 20&amp;nbsp;μg/kg weekly induced an increase in bone mass,
 changes in bone microarchitecture, and decreased vertebral fractures.
 
 
	Content Type Journal ArticlePages 1-12DOI 10.1007/s00223-011-9480-6Authors
		Valerie Geoffroy, INSERM U606, University Paris Diderot, Hôpital Lariboisière, Centre Viggo Petersen, 2 rue Ambroise Paré, 75010 Paris, FranceEleftherios P. Paschalis, Ludwig Boltzman Institute of Osteology at the Hanusch Hospital of WGKK, Heinrich Collin-Str. 30, 1140 Vienna, AustriaHelene Libouban, INSERM U922, LHEA Faculté de Médecine, 1 rue Haute de Reculée, 49045 Angers Cedex, FranceStephane Blouin, Ludwig Boltzman Institute of Osteology at the Hanusc...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4678696</comments>
            <pubDate>Thu, 31 Mar 2011 17:40:38 +0100</pubDate>
            <guid isPermaLink="false">4678696</guid>        </item>
        <item>
            <title>Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation</title>
            <link>http://www.medworm.com/index.php?rid=4672820&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6t4hq50413712512%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00223-011-9479-zAuthors
		Geeta Hampson, Department of Chemical Pathology/Metabolic Bone Clinic, Guy’s and St Thomas’ NHS Foundation Trust, London, SE1 7EH UK
	

	
		Journal Calcified Tissue InternationalOnline ISSN 1432-0827Print ISSN 0171-967X (Source: Calcified Tissue International)</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4672820</comments>
            <pubDate>Wed, 30 Mar 2011 23:54:04 +0100</pubDate>
            <guid isPermaLink="false">4672820</guid>        </item>
        <item>
            <title>Supplementation with Green Tea Polyphenols Improves Bone Microstructure and Quality in Aged, Orchidectomized Rats</title>
            <link>http://www.medworm.com/index.php?rid=4633404&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm156mx6288u74603%2F</link>
            <description>This study evaluated the efficacy of GTPs at mitigating bone loss
 and microstructure deterioration along with related mechanisms in androgen-deficient aged rats, a model of male osteoporosis.
 A 2 (sham vs. orchidectomy)&amp;nbsp;×&amp;nbsp;2 (no GTP and 0.5% GTP in drinking water) factorial design was studied for 16&amp;nbsp;weeks using 40
 aged male rats. An additional 10 rats (baseline group) were killed at the beginning of study to provide baseline parameters.
 There was no difference in femoral mineral density between baseline and the sham only group. Orchidectomy suppressed serum
 testosterone and tartrate-resistant acid phosphatase concentrations, liver glutathione peroxidase activity, bone mineral density,
 and bone strength. Orchidectomy also decreased trabecular bone volume, number, and th...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4633404</comments>
            <pubDate>Tue, 22 Mar 2011 18:11:22 +0100</pubDate>
            <guid isPermaLink="false">4633404</guid>        </item>
        <item>
            <title>Voluntary Exercise has Long-Term In Vivo Protective Effects on Osteocyte Viability and Bone Strength Following Ovariectomy</title>
            <link>http://www.medworm.com/index.php?rid=4618232&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3q815p2414246293%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Osteocytes are recognized as having a pivotal role in bone tissue homeostasis, and stimuli that increase osteocyte death result
 in decreased bone tissue quality. Previous in vitro studies have shown that mechanical stimulation prevents osteocyte death;
 however, in vivo evidence of this protective effect is limited. The aim of this study was to investigate if mechanical stimulation
 provided by voluntary exercise reduces osteocyte death caused by estrogen deficiency. Thirty-two female Wistar rats (5&amp;nbsp;months
 old) were either sacrificed as baseline controls (BSL, n&amp;nbsp;=&amp;nbsp;7), ovariectomized or sham-operated and housed in cages with a voluntary running wheel (OVXEX, n&amp;nbsp;=&amp;nbsp;7; SHAMEX, n&amp;nbsp;=&amp;nbsp;6), or ovariectomized or sham-operated and housed in stand...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4618232</comments>
            <pubDate>Thu, 17 Mar 2011 18:32:54 +0100</pubDate>
            <guid isPermaLink="false">4618232</guid>        </item>
        <item>
            <title>Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation</title>
            <link>http://www.medworm.com/index.php?rid=4618234&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj3g0l67441552510%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00223-011-9478-0Authors
		James Mahon, Osteoporosis Treatment and Bone Protection Clinic, Department of Medicine for the Elderly, St. James’s Hospital, Dublin 8, IrelandMiriam Casey, Osteoporosis Treatment and Bone Protection Clinic, Department of Medicine for the Elderly, St. James’s Hospital, Dublin 8, Ireland
	

	
		Journal Calcified Tissue InternationalOnline ISSN 1432-0827Print ISSN 0171-967X (Source: Calcified Tissue International)</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4618234</comments>
            <pubDate>Thu, 17 Mar 2011 18:32:53 +0100</pubDate>
            <guid isPermaLink="false">4618234</guid>        </item>
        <item>
            <title>In Vivo CT Quantification of Trabecular Bone Dynamics in Mice after Sciatic Neurectomy Using Monochromatic Synchrotron Radiation</title>
            <link>http://www.medworm.com/index.php?rid=4537637&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv3488r14q5g2qr50%2F</link>
            <description>In conclusion, in
 vivo SRCT has potential use for detecting short-term bone dynamics of small animals.
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s00223-011-9475-3Authors
		Takeshi Matsumoto, Division of Bioengineering, Osaka University Graduate School of Engineering Science, Machikaneyama-cho 1-3, Toyonaka, 560-8531 JapanKen Nishikawa, Division of Bioengineering, Osaka University Graduate School of Engineering Science, Machikaneyama-cho 1-3, Toyonaka, 560-8531 JapanMasao Tanaka, Division of Bioengineering, Osaka University Graduate School of Engineering Science, Machikaneyama-cho 1-3, Toyonaka, 560-8531 JapanKentaro Uesugi, SPring-8/Japan Synchrotron Radiation Research Institute, Kouto, 679-5198 Japan
	

	
		Journal Calcified Tissue InternationalOnline ISSN 1432-0827Print ISS...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4537637</comments>
            <pubDate>Sat, 26 Feb 2011 15:20:21 +0100</pubDate>
            <guid isPermaLink="false">4537637</guid>        </item>
        <item>
            <title>The Three-Dimensional Morphometry and Cell–Cell Communication of the Osteocyte Network in Chick and Mouse Embryonic Calvaria</title>
            <link>http://www.medworm.com/index.php?rid=4509076&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg42050584r44155w%2F</link>
            <description>We examined whether chick osteocyte data can be applied to other species.
 We used mice for comparison because they are common clinical tools in biomedical research and useful for future study. We
 analyzed the three-dimensional (3D) osteocyte network and gap junctional intercellular communication (GJIC) in living embryonic
 calvaria for the anatomical features. Embryonic parietal bones were stained with fluorescently labeled phalloidin and observed
 using confocal laser scanning microscopy. GJIC between osteocytes in chick and mouse parietal bone was assessed using fluorescence
 recovery after photobleaching (FRAP). The values for one chick and mouse osteocyte, respectively, were calculated as follows:
 cell processes 1,131&amp;nbsp;±&amp;nbsp;139&amp;nbsp;μm, 2,668&amp;nbsp;±&amp;nbsp;596&amp;nbsp;μm; surfa...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4509076</comments>
            <pubDate>Mon, 21 Feb 2011 17:05:06 +0100</pubDate>
            <guid isPermaLink="false">4509076</guid>        </item>
        <item>
            <title>Microdamage Accumulation Changes According to Animal Mass: An Intraspecies Investigation</title>
            <link>http://www.medworm.com/index.php?rid=4499096&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk4h805626226j333%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The fatigue life of a structure is also influenced by its size. Statistically, a bone from a large animal is expected to bear
 a higher risk of stress fracture if compared to the same bone from a small animal of the same species. This is not documented
 in the dog, where individuals can have a 40 times difference in body mass. We investigated the effect of body size on cortical bone microdamage accumulation, cortical microstructural organization
 (porosity, osteon area, and osteocyte lacunar density), and turnover in dogs with a wide body mass range. The aim was to understand
 and mathematically model how the bone tissue copes with the microdamage accumulation linked to body mass increase. Calcified
 transverse cortical sections of 18 canine radii of remarkably differen...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4499096</comments>
            <pubDate>Thu, 17 Feb 2011 17:04:18 +0100</pubDate>
            <guid isPermaLink="false">4499096</guid>        </item>
        <item>
            <title>Clinical Risk Factors for Recurrent Fracture after Hip Fracture: A Prospective Study</title>
            <link>http://www.medworm.com/index.php?rid=4499097&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj716162r77kp6632%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Additional fractures after hip fracture are common, but little is known about the risk factors associated with these events.
 We determined the clinical risk factors associated with fracture following a low-trauma hip fracture and whether clinical
 risk factors for subsequent fracture were modified by zoledronic acid (ZOL). In this post hoc analysis of the HORIZON Recurrent
 Fracture trial, 2,127 men and women were randomized within 90&amp;nbsp;days of surgical hip fracture repair to receive intravenous
 ZOL 5&amp;nbsp;mg yearly or placebo. All patients received a loading dose of vitamin D and daily oral calcium and vitamin D supplements.
 In the multivariable model age, sex, BMI, femoral neck T score, and one or more fall risk factors were significant predictors of subsequent ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4499097</comments>
            <pubDate>Thu, 17 Feb 2011 17:04:16 +0100</pubDate>
            <guid isPermaLink="false">4499097</guid>        </item>
        <item>
            <title>Effects of Alfacalcidol on Mechanical Properties and Collagen Cross-Links of the Femoral Diaphysis in Glucocorticoid-Treated Rats</title>
            <link>http://www.medworm.com/index.php?rid=4491677&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp624656770365q78%2F</link>
            <description>This study was conducted to clarify the
 effects of GC on bone strength and collagen cross-links of adult rats and the effect of coadministration of alfacalcidol (ALF),
 a prodrug of active vitamin D3. Six-month-old male Wistar-Imamichi rats (n&amp;nbsp;=&amp;nbsp;32) were divided into the following four groups with equal average body weight: (1) 4-week age-matched controls, (2) 4-week
 GC (prednisolone, 10&amp;nbsp;mg/kg daily, i.m.) with concomitant administration of vehicle, (3) 4-week GC with concomitant administration
 of ALF (0.05&amp;nbsp;μg/kg daily, p.o.), and (4) 4-week GC with concomitant administration of ALF (0.1&amp;nbsp;μg/kg daily, p.o.). At the
 end of treatment, BMD, collagen cross-links, mechanical properties of the femoral midshaft, bone metabolic markers, and biochemical
 parameters wer...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4491677</comments>
            <pubDate>Wed, 16 Feb 2011 07:07:49 +0100</pubDate>
            <guid isPermaLink="false">4491677</guid>        </item>
        <item>
            <title>Erratum to: Age-Related Changes in Collagen Properties and Mineralization in Cancellous and Cortical Bone in the Porcine Mandibular Condyle</title>
            <link>http://www.medworm.com/index.php?rid=4491679&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F66155u86841242p8%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00223-011-9469-1Authors
		Nop M. B. K. Willems, Department of Orthodontics, Academic Center for Dentistry Amsterdam, University of Amsterdam and VU University, Gustav Mahlerlaan 3004, 1081 LA Amsterdam, The NetherlandsGeerling E. J. Langenbach, Department of Functional Anatomy, Research Institute MOVE, Academic Center for Dentistry Amsterdam, University of Amsterdam and VU University, Gustav Mahlerlaan 3004, 1081 LA Amsterdam, The NetherlandsVincent Everts, Department of Oral Cell Biology, Research Institute MOVE, Academic Center for Dentistry Amsterdam, University of Amsterdam and VU University, Gustav Mahlerlaan 3004, 1081 LA Amsterdam, The NetherlandsLars Mulder, Department of Functional Anatomy, Research Institute MOVE, Academic Cente...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4491679</comments>
            <pubDate>Wed, 16 Feb 2011 07:07:48 +0100</pubDate>
            <guid isPermaLink="false">4491679</guid>        </item>
        <item>
            <title>Reduced Osteoclastogenesis and RANKL Expression in Marrow from Women Taking Alendronate</title>
            <link>http://www.medworm.com/index.php?rid=4491678&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn630702717jl7l87%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Alendronate (AL) is commonly used for the prevention and treatment of osteoporotic fractures. Little is known about the effects
 of AL administration on osteoclast differentiation from human marrow progenitor cells. We used marrow discarded during orthopedic
 surgery to test the hypothesis that cultures of bone marrow-derived stem cells (BMCs) from subjects receiving AL (+AL) may
 differ from control subjects with respect to in&amp;nbsp;vitro osteoclast differentiation and regulatory factors. The number of osteoclasts
 generated in BMC cultures from control subjects was 4.7-fold greater than that from +AL subjects (P&amp;nbsp;=&amp;nbsp;0.015). RANKL expression in +AL BMCs was 57% of that in controls (P&amp;nbsp;=&amp;nbsp;0.001), and OPG expression in +AL BMCs was greater than in controls...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4491678</comments>
            <pubDate>Wed, 16 Feb 2011 07:07:48 +0100</pubDate>
            <guid isPermaLink="false">4491678</guid>        </item>
        <item>
            <title>Fragility Fractures in Men with Idiopathic Osteoporosis Are Associated with Undermineralization of the Bone Matrix without Evidence of Increased Bone Turnover</title>
            <link>http://www.medworm.com/index.php?rid=4485766&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F52g2m3306x086248%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The pathogenesis of primary osteoporosis in younger individuals is still elusive. An important determinant of the biomechanical
 competence of bone is its material quality. In this retrospective study we evaluated bone material quality based on quantitative
 backscattered electron imaging to assess bone mineralization density distribution (BMDD) in bone biopsies of 25 male patients
 (aged 18–61&amp;nbsp;years) who sustained fragility fractures but were otherwise healthy. BMDD of cancellous bone was compared with
 previously established adult reference data. Complementary information was obtained by bone histomorphometry. The histomorphometric
 results showed a paucity of osteoblasts and osteoclasts on the bone surface in the majority of patients. BMDD revealed a significa...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4485766</comments>
            <pubDate>Mon, 14 Feb 2011 07:05:16 +0100</pubDate>
            <guid isPermaLink="false">4485766</guid>        </item>
        <item>
            <title>A Scaffold-Free Multicellular Three-Dimensional In Vitro Model of Osteogenesis</title>
            <link>http://www.medworm.com/index.php?rid=4485767&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flk645v84t4x48228%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In vitro models of osteogenesis are essential for investigating bone biology and the effects of pharmaceutical, chemical,
 and physical cues on bone formation. Osteogenesis takes place in a complex three-dimensional (3D) environment with cells from
 both mesenchymal and hematopoietic origins. Existing in vitro models of osteogenesis include two-dimensional (2D) single type
 cell monolayers and 3D cultures. However, an in vitro scaffold-free multicellular 3D model of osteogenesis is missing. We
 hypothesized that the self-inductive ossification capacity of bone marrow tissue can be harnessed in vitro and employed as
 a scaffold-free multicellular 3D model of osteogenesis. Therefore, rat bone marrow tissue was cultured for 28&amp;nbsp;days in three
 settings: 2D monolayer, 3D...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4485767</comments>
            <pubDate>Mon, 14 Feb 2011 07:05:15 +0100</pubDate>
            <guid isPermaLink="false">4485767</guid>        </item>
        <item>
            <title>No Effect of Rosuvastatin in the Zoledronate-Induced Acute-Phase Response</title>
            <link>http://www.medworm.com/index.php?rid=4461639&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F893kg47w47n23795%2F</link>
            <description>In conclusion, our data suggest that a short course of ROS at this dose cannot prevent the ZOL-induced APR
 among osteoporotic women. Milder changes in acute-phase laboratory parameters in ROSU+ patients suggest that studies with
 higher doses may be warranted.
 
 
	Content Type Journal ArticlePages 1-7DOI 10.1007/s00223-011-9468-2Authors
		Polyzois Makras, Department of Endocrinology and Diabetes, 251 Hellenic Air Force and VA General Hospital, 3 Kanellopoulou St, 115 25 Athens, GreeceAthanasios D. Anastasilakis, Department of Endocrinology, 424 Military Hospital, Thessaloniki, GreeceStergios A. Polyzos, Second Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, GreeceIlias Bisbinas, First Department of Orthopaedics, 424 Mili...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4461639</comments>
            <pubDate>Tue, 08 Feb 2011 21:46:05 +0100</pubDate>
            <guid isPermaLink="false">4461639</guid>        </item>
        <item>
            <title>Three Novel Mutations in the PHEX Gene in Chinese Subjects with Hypophosphatemic Rickets Extends Genotypic Variability</title>
            <link>http://www.medworm.com/index.php?rid=4440046&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa7n1110845558024%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mutations in the phosphate-regulating endopeptidase homolog, X-linked, gene (PHEX), which encodes a zinc-dependent endopeptidase that is involved in bone mineralization and renal phosphate reabsorption,
 cause the most common form of hypophosphatemic rickets, X-linked hypophosphatemic rickets (XLH). The distribution of PHEX mutations is extensive, but few mutations have been identified in Chinese with XLH. We extracted genomic DNA and total RNA
 from leukocytes obtained from nine unrelated Chinese subjects (three males and six females, age range 11–36&amp;nbsp;years) who were
 living in Taiwan. The PHEX gene was amplified from DNA by PCR, and the amplicons were directly sequenced. Expression studies were performed by reverse-transcription
 PCR of leukocyte RNA. Serum leve...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4440046</comments>
            <pubDate>Fri, 04 Feb 2011 03:33:03 +0100</pubDate>
            <guid isPermaLink="false">4440046</guid>        </item>
        <item>
            <title>Role of Parathyroid Hormone in Bone Fragility of Postmenopausal Women with Vitamin D Insufficiency</title>
            <link>http://www.medworm.com/index.php?rid=4440047&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyx722w1541262824%2F</link>
            <description>In conclusion, vitamin D insufficiency was found to be related to prevalent fracture risk independently
 of PTH. Functional hypoparathyroidism, rather than functional hyperparathyroidism, might be a risk factor for bone fragility
 in vitamin D insufficiency.
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s00223-011-9464-6Authors
		Mika Yamauchi, Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, JapanHiroshi Kaji, Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, JapanKiyoko Nawata, Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, JapanShin Takaoka, Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, JapanToru Yamaguchi, ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4440047</comments>
            <pubDate>Thu, 03 Feb 2011 07:11:23 +0100</pubDate>
            <guid isPermaLink="false">4440047</guid>        </item>
        <item>
            <title>Bone Mass and Bone Size in Pre- or Early Pubertal 10-Year-Old Black and White South African Children and Their Parents</title>
            <link>http://www.medworm.com/index.php?rid=4416189&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F40854727wp547475%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Genetic factors are thought to maintain bone mass in socioeconomically disadvantaged black South Africans. We compared bone
 mass between environmentally disadvantaged black and advantaged white children and their parents, after determining the most
 appropriate method by which to correct bone mineral content (BMC) for size. We collected data from 419 healthy black and white
 children of mean age 10.6 years (range 10.0–10.9), 406 biological mothers, and 100 biological fathers. Whole-body, femoral
 neck, lumbar spine, and mid- and distal one-third of radius bone area (BA) and BMC were measured by dual-energy X-ray absorptiometry.
 Power coefficients (PCs) were calculated from the linear-regression analyses of ln(BMC) on ln(BA) and used to correct site-specific
 BMC for...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4416189</comments>
            <pubDate>Thu, 27 Jan 2011 17:36:11 +0100</pubDate>
            <guid isPermaLink="false">4416189</guid>        </item>
        <item>
            <title>Minerals Form a Continuum Phase in Mature Cancellous Bone</title>
            <link>http://www.medworm.com/index.php?rid=4430424&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk23n653n77348502%2F</link>
            <description>The objective of this study was to investigate the hierarchical structure of mineral in mature bone. A method to
 completely deproteinize bone without altering the original structure is developed, and the completion is confirmed by protein
 analysis techniques. Stereoscopy and field emission electron microscopy are used to examine the structural features from submillimeter-
 to micrometer- to nanometer-length scales of bovine femur cancellous bone. Stereoscopic images of fully deproteinized and
 demineralized bovine femur cancellous bone samples show that fine trabecular architecture is unaltered and the microstructural
 features are preserved, indicating the structural integrity of mineral and protein constituents. SEM revealed that bone minerals
 are fused together and form a sheet-like ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4430424</comments>
            <pubDate>Thu, 27 Jan 2011 17:36:10 +0100</pubDate>
            <guid isPermaLink="false">4430424</guid>        </item>
        <item>
            <title>Overexpression of Runx2 and MKP-1 Stimulates Transdifferentiation of 3T3-L1 Preadipocytes into Bone-Forming Osteoblasts In Vitro</title>
            <link>http://www.medworm.com/index.php?rid=4402152&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjjv370m757h561h8%2F</link>
            <description>We examined
 the effect of Runx2 on transdifferentiation of 3T3-L1 preadipocytes into functional, mature osteoblasts. Forced expression
 of exogenous Runx2 using a retroviral gene-delivery system showed increases of alkaline phosphatase (ALP) activity and expression
 of the osteoblastic marker genes osteocalcin (OC), bone sialoprotein (BSP), and osterix (Osx), accompanied by low-level matrix
 mineralization. In contrast, adipocytic differentiation was completely blocked with downregulation of adipogenic transcription
 factors PPARγ2, C/EBPα, and C/EBPδ. Treatment of dexamethasone (Dex), a synthetic glucocorticoid, stimulated the formation
 of mineralized nodules in Runx2-overexpressing 3T3-L1 cells with increases of ALP, OC, BSP, and Osx expression. Here, we focused
 on a dual specific ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4402152</comments>
            <pubDate>Sat, 22 Jan 2011 07:57:54 +0100</pubDate>
            <guid isPermaLink="false">4402152</guid>        </item>
        <item>
            <title>Use of Bisphosphonates and Risk of Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=4402153&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk10j57505086j263%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A decreased risk of breast cancer has been reported among patients given bisphosphonates. The present aims were to study potential
 associations between different antiosteoporosis drugs, including bisphosphonates, and the risk of breast cancer before and
 after start of treatment and to appraise possible dose–effect relationships. From national Danish registers, all female users
 of bisphosphonates aged&amp;nbsp;≥40&amp;nbsp;years and other drugs against osteoporosis between 1996 and 2006 were identified (n&amp;nbsp;=&amp;nbsp;87,104). This cohort was compared with a control group, where each patient was matched on age with three nonexposed women
 from the general population (n&amp;nbsp;=&amp;nbsp;261,322). Before start of most drugs against osteoporosis an increased risk of breast cancer ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4402153</comments>
            <pubDate>Fri, 21 Jan 2011 15:18:06 +0100</pubDate>
            <guid isPermaLink="false">4402153</guid>        </item>
        <item>
            <title>Predictors of Bone Responsiveness to Growth Hormone (GH) Replacement in Adult GH-Deficient Patients</title>
            <link>http://www.medworm.com/index.php?rid=4402154&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3355367177333573%2F</link>
            <description>This study confirms that bone responsiveness to GH replacement in adult GHD varies as a function of sex even after controlling
 for potential confounders and highlights the importance of other cofactors that may affect the interaction between GH replacement
 therapy and bone remodeling.
 
 
	Content Type Journal ArticlePages 1-10DOI 10.1007/s00223-010-9459-8Authors
		Alessandro Rossini, Endocrinology Unit, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, ItalyRoberto Lanzi, Endocrinology Unit, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, ItalyMarco Losa, Neurosurgery Unit, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, ItalyMarcella Sirtori, Bone Metabolic Unit, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, ItalyE...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4402154</comments>
            <pubDate>Fri, 21 Jan 2011 15:18:05 +0100</pubDate>
            <guid isPermaLink="false">4402154</guid>        </item>
        <item>
            <title>Calcium Plus Vitamin D Supplementation Has Limited Effects on Femoral Geometric Strength in Older Postmenopausal Women: The Women’s Health Initiative</title>
            <link>http://www.medworm.com/index.php?rid=4402155&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj25t3677vw746v00%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Calcium plus vitamin D (CaD) supplementation has a modest but significant effect on slowing loss of femoral bone mass and
 reducing risk of hip fractures in adherent postmenopausal women. The goal of this study was to determine if CaD supplementation
 influences hip structural parameters that are associated with fracture risk. We studied 1,970 postmenopausal women enrolled
 in the Women’s Health Initiative randomized controlled trial of CaD at one of three bone mineral density (BMD) clinical centers.
 Hip structural analysis software measured BMD and strength parameters on DXA scans at three regions: femoral narrow neck,
 intertrochanter, and shaft. Random effects models were used to test the average differences in hip BMD and geometry between
 intervention and placeb...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4402155</comments>
            <pubDate>Fri, 21 Jan 2011 15:18:03 +0100</pubDate>
            <guid isPermaLink="false">4402155</guid>        </item>
        <item>
            <title>Parathyroid Hormone Treatment Increases Fixation of Orthopedic Implants with Gap Healing: A Biomechanical and Histomorphometric Canine Study of Porous Coated Titanium Alloy Implants in Cancellous Bone</title>
            <link>http://www.medworm.com/index.php?rid=4402156&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F28467k5755215453%2F</link>
            <description>We examined the effect of human
 PTH(1–34) on implant fixation in an experimental gap model. We inserted cylindrical (10&amp;nbsp;×&amp;nbsp;6&amp;nbsp;mm) porous coated titanium alloy
 implants in a concentric 1-mm gap in normal cancellous bone of proximal tibia in 20 canines. Animals were randomized to treatment
 with PTH(1–34) 5&amp;nbsp;μg/kg daily. After 4&amp;nbsp;weeks, fixation was evaluated by histomorphometry and push-out test. Bone volume was
 increased significantly in the gap. In the outer gap (500&amp;nbsp;μm), the bone volume fraction median (interquartile range) was 27%
 (20–37%) for PTH and 10% (6–14%) for control. In the inner gap, the bone volume fraction was 33% (26–36%) for PTH and 13%
 (11–18%) for control. At the implant interface, the bone fraction improved with 16% (11–20...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4402156</comments>
            <pubDate>Fri, 21 Jan 2011 15:18:02 +0100</pubDate>
            <guid isPermaLink="false">4402156</guid>        </item>
        <item>
            <title>[Without Title]</title>
            <link>http://www.medworm.com/index.php?rid=4374392&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9294agp2121ut5lv%2F</link>
            <description>Content Type Journal Article

	
		Journal Calcified Tissue InternationalOnline ISSN 1432-0827Print ISSN 0171-967X (Source: Calcified Tissue International)</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4374392</comments>
            <pubDate>Thu, 20 Jan 2011 18:35:11 +0100</pubDate>
            <guid isPermaLink="false">4374392</guid>        </item>
        <item>
            <title>Osteoblast Response to Ovariectomy Is Enhanced in Intrinsically High Aerobic-Capacity Rats</title>
            <link>http://www.medworm.com/index.php?rid=4325316&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F703g848548360m52%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The role of exercise in promoting bone health is typically attributed to increased mechanical loading, which induces functional
 adaptation. Recent evidence suggests that habitual aerobic exercise has influence at the cellular level as well. The effect
 of aerobic capacity on osteoblast-lineage cell differentiation and function as well as skeletal phenotype is unknown. Using
 a rat model of high-capacity and low-capacity runners (HCRs and LCRs, respectively), in which an intrinsic functional genomic
 difference in aerobic capacity exists between nontrained animals, this study evaluated the effects of aerobic capacity on
 measures of bone mass and strength as well as osteoblast activity following ovariectomy. The ovariectomized rat emulates the
 clinical features of the ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4325316</comments>
            <pubDate>Thu, 06 Jan 2011 17:57:41 +0100</pubDate>
            <guid isPermaLink="false">4325316</guid>        </item>
        <item>
            <title>P2Y1 Transient Overexpression Induced Mineralization in Spinal Ligament Cells Derived from Patients with Ossification of the Posterior Longitudinal Ligament of the Cervical Spine</title>
            <link>http://www.medworm.com/index.php?rid=4319948&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp55t15j48766n784%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ossification of the posterior longitudinal ligament of the spine (OPLL) is characterized by ectopic bone formation in the
 spinal ligaments. We previously reported that P2 purinoceptor Y1 (P2Y1) expression is elevated in the spinal ligament cells
 of OPLL patients, but the role of P2Y1 in the spinal ligament calcification process is unknown. To verify the hypothesis that
 P2Y1 expression causes ossification of the spinal ligaments, we forced expression of P2Y1 in spinal ligament cells obtained
 from OPLL and non-OPLL patients using a cytomegaloviral vector. The expression of mRNA and protein was investigated by quantitative
 real-time polymerase chain reaction and immunofluorescence staining, respectively. After transfection, bone morphogenetic
 protein-2 (BMP-2) and So...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4319948</comments>
            <pubDate>Wed, 05 Jan 2011 16:54:18 +0100</pubDate>
            <guid isPermaLink="false">4319948</guid>        </item>
        <item>
            <title>Interplay Between Serum Osteocalcin and Insulin Sensitivity in Primary Hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=4319950&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj3188177v4333303%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Osteocalcin (OC) has been proposed as a regulator of insulin sensitivity in both humans and other animals. Primary hyperparathyroidism
 (PHPT) is characterized by high OC levels and insulin resistance. The aim of this study was to evaluate whether in PHPT the
 link between OC levels and blood markers of insulin resistance was maintained. In a consecutive series of 219 adult PHPT patients,
 serum OC as well as fasting insulin and glucose levels were measured. Insulin sensitivity was estimated by homeostatic model
 assessment (HOMA2-S%). The same parameters were evaluated in a subgroup of 45 patients after parathyroidectomy (PTX). PHPT
 patients were characterized by markedly high OC levels. After subdividing them according to glucose tolerance, it was found
 that OC was ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4319950</comments>
            <pubDate>Tue, 04 Jan 2011 17:49:52 +0100</pubDate>
            <guid isPermaLink="false">4319950</guid>        </item>
        <item>
            <title>Role of Melastatin Transient Receptor Potential 7 Channels in the Osteoblastic Differentiation of Murine MC3T3 Cells</title>
            <link>http://www.medworm.com/index.php?rid=4319949&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F321608r644g016x2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Adequate bone formation is assured by the coordinated proliferation, migration, differentiation, and secretory functions of
 osteoblasts. Epidemiological studies have linked insufficient dietary magnesium (Mg) intake to osteoporosis. Here, we investigated
 the role of melastatin-like transient receptor potential 7 (TRPM7), a calcium (Ca) and Mg channel, in osteoblastic differentiation
 of the murine MC3T3 cell line. Osteoblastic differentiation was monitored by alkaline phosphatase activity, osteocalcin gene
 expression, and extracellular matrix mineralization. Gene expression of TRPM7 increased with osteoblastic differentiation,
 suggesting the importance of intracellular Ca/Mg homeostasis to cell differentiation. Alteration of intracellular Ca/Mg homeostasis
 by cultu...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4319949</comments>
            <pubDate>Tue, 04 Jan 2011 17:49:52 +0100</pubDate>
            <guid isPermaLink="false">4319949</guid>        </item>
        <item>
            <title>Localization and Expression of Prothrombin in Rodent Osteoclasts and Long Bones</title>
            <link>http://www.medworm.com/index.php?rid=4301347&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F06m1577485689327%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The serum protein prothrombin (PT) is proteolytically converted to thrombin during the coagulation cascade by the cell-associated
 prothrombinase complex. In vitro, RANKL-differentiated osteoclasts express tissue factor and coagulation factor Xa, which
 convert PT to thrombin (Karlstrom et al. Biochem Biophys Res Commun 394:593–599, 2010). The present study investigated the localization of PT in bone as well as the expression of PT mRNA in bone and osteoclasts.
 Herein, immunoblot analysis detected PT and smaller proteolytically cleaved fragments with sizes consistent with the action
 of prothrombinase in a protein fraction extracted with guanidine-HCl EDTA from mouse tibia. Light microscopic and ultrastructural
 immunohistochemistry demonstrated the presence of PT in...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4301347</comments>
            <pubDate>Wed, 29 Dec 2010 17:08:42 +0100</pubDate>
            <guid isPermaLink="false">4301347</guid>        </item>
        <item>
            <title>Increased Fracture Risk in Normocalcemic Postmenopausal Women with High Parathyroid Hormone Levels: A 16-Year Follow-Up Study</title>
            <link>http://www.medworm.com/index.php?rid=4288051&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F39l37767h30tu854%2F</link>
            <description>In conclusion, PTH levels in the upper part or above the upper level of the reference
 interval increase risk of fracture in the presence of low vitamin D levels.
 
 
	Content Type Journal ArticleDOI 10.1007/s00223-010-9454-0Authors
		Lars Rejnmark, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus Sygehus, Tage-Hansens Gade 2, 8000 Aarhus C, DenmarkPeter Vestergaard, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus Sygehus, Tage-Hansens Gade 2, 8000 Aarhus C, DenmarkChristine Brot, The Osteoporosis and Metabolic Research Unit, Copenhagen University Hospital Hvidovre, Hvidovre, DenmarkLeif Mosekilde, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus Sygehus, Tage-Hansens Gade 2, 800...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4288051</comments>
            <pubDate>Wed, 22 Dec 2010 20:10:38 +0100</pubDate>
            <guid isPermaLink="false">4288051</guid>        </item>
        <item>
            <title>Quantitative Ultrasound Measurements in Premature Infants at 1 Year of Age: The Effects of Antenatal Administered Corticosteroids</title>
            <link>http://www.medworm.com/index.php?rid=4288050&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3n225n4751421466%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this study was to evaluate the effects of antenatally administered glucocorticoids on bone status of preterm infants
 at 1&amp;nbsp;year corrected age. The study population consisted of 32 preterm infants with a gestational age of 24–34&amp;nbsp;weeks. The infants
 were divided into two groups according to antenatal exposure to corticosteroids. Quantitative ultrasound (QUS) assessment
 of bone was performed in the study infants at the corrected age of 1&amp;nbsp;year. Blood levels of carboxy-terminal propeptide of
 type I procollagen (PICP) and carboxy-terminal telopeptide of type I collagen (ICTP) were measured at birth and at 1&amp;nbsp;year
 corrected age. Levels of PICP and ICTP were significantly lower at birth in corticosteroid-exposed neonates (P&amp;nbsp;&amp;lt;&amp;nbsp;0.05...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4288050</comments>
            <pubDate>Wed, 22 Dec 2010 20:10:38 +0100</pubDate>
            <guid isPermaLink="false">4288050</guid>        </item>
        <item>
            <title>Does Anastrozole Affect Bone Resorption Similarly in Early and Late Postmenopausal Women?</title>
            <link>http://www.medworm.com/index.php?rid=4279243&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy74678821qm28276%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this study was to determine whether the bone-resorption response to anastrozole differed according to initial patient
 age in postmenopausal women with breast cancer in a cross-sectional study. Second-morning void urines were collected for measurement
 of urinary cross-linked N-telopeptide of type I collagen (uNTx, corrected for creatinine and log-transformed) from postmenopausal
 women, 99 with breast cancer on anastrozole (ABC), 88 with newly diagnosed breast cancer (NDBC), and 137 community-dwelling
 healthy control (HC) women. Bone mineral density (BMD) was also measured at the lumbar spine (LS, L2–L4) and the femoral neck
 (FN) in the ABC group. uNTx (nanomole bone collagen equivalents/millimole creatinine) levels increased with age in HC subjects.
 In...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4279243</comments>
            <pubDate>Mon, 20 Dec 2010 15:19:35 +0100</pubDate>
            <guid isPermaLink="false">4279243</guid>        </item>
        <item>
            <title>Steady and Oscillatory Fluid Flows Produce a Similar Osteogenic Phenotype</title>
            <link>http://www.medworm.com/index.php?rid=4273740&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm244300h523370p1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mechanical loading induces positive changes in the skeleton due to direct effects on bone cells, which may include regulation
 of transcription factors that support osteoblast differentiation and function. Flow effects on osteoblast transcription factors
 have generally been evaluated after short exposures. In this work, we assayed flow effects on osteogenic genes at early and
 late time points in a preosteoblast (CIMC-4) cell line and evaluated both steady and oscillatory flows. Four hours of steady
 unidirectional flow decreased the level of RANKL mRNA 53 ± 7% below that of nonflowed cells, but increases in Runx2 and osterix
 mRNA (44 ± 22% and 129 ± 12%, respectively) were significant only after 12–19&amp;nbsp;h of continuous flow. Late flow effects on RANKL
 and os...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4273740</comments>
            <pubDate>Thu, 16 Dec 2010 18:23:58 +0100</pubDate>
            <guid isPermaLink="false">4273740</guid>        </item>
        <item>
            <title>Are Antiresorptive Drugs Effective Against Fractures in Patients with Diabetes?</title>
            <link>http://www.medworm.com/index.php?rid=4269166&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff2k358k342744272%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We studied whether the reduction in bone turnover by use of antiresorptive drugs is detrimental in patients with diabetes
 who already have low bone turnover due to hyperglycemia in a nationwide cohort study from Denmark. All users of antiresorptive
 drugs against osteoporosis between 1996 and 2006 (n&amp;nbsp;=&amp;nbsp;103,562) were the exposed group, with three age- and gender-matched controls from the general population (n&amp;nbsp;=&amp;nbsp;310,683). Patients on bisphosphonates and raloxifene had a higher risk of hip, spine, and forearm fractures. However, no
 difference was observed in the antifracture efficacy between patients with diabetes and nondiabetic controls or between patients
 with type 1 and type 2 diabetes. Too few were users of strontium to allow analysis for this c...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4269166</comments>
            <pubDate>Wed, 15 Dec 2010 19:07:57 +0100</pubDate>
            <guid isPermaLink="false">4269166</guid>        </item>
        <item>
            <title>Effect of Calcium and the Calcimimetic AMG 641 on Matrix-Gla Protein in Vascular Smooth Muscle Cells</title>
            <link>http://www.medworm.com/index.php?rid=4269167&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn13224v21k208227%2F</link>
            <description>In conclusion, selective
 CaSR activation, either by extracellular calcium or AMG 641, increased MGP expression in vivo in the arterial wall and in
 vitro in bovine VSMCs. This local upregulation of MGP expression provides one potential mechanism by which calcimimetics prevent
 VC.
 
 
	Content Type Journal ArticleDOI 10.1007/s00223-010-9442-4Authors
		Francisco J. Mendoza, Departamento de Medicina y Cirugia Animal, Universidad de Cordoba, Campus Universitario Rabanales, Ctra. Madrid-Cadiz km 396, 14014, Cordoba, SpainJulio Martinez-Moreno, Unidad de Investigacion, Servicio de Nefrologia, Hospital Universitario Reina Sofia, Avda Menedez Pidal s/n, 14004 Cordoba, SpainYolanda Almaden, Unidad de Investigacion, Servicio de Nefrologia, Hospital Universitario Reina Sofia, Avda Menedez Pidal s/n...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4269167</comments>
            <pubDate>Wed, 15 Dec 2010 19:07:56 +0100</pubDate>
            <guid isPermaLink="false">4269167</guid>        </item>
        <item>
            <title>Assessment of the Impact of Two Different Isolation Methods on the Osteo/Odontogenic Differentiation Potential of Human Dental Stem Cells Derived from Deciduous Teeth</title>
            <link>http://www.medworm.com/index.php?rid=4269168&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fev2578664484v052%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Human deciduous teeth have been proposed as a promising source of mesenchymal stem cells for application in bone and dental
 tissue engineering. We established cultures of mesenchymal stem cells from the pulp of human deciduous teeth (deciduous teeth
 stem cells, DTSCs) and analyzed their morphologic, growth, immunophenotypic, and osteo/odontogenic differentiation characteristics
 using different isolation methods and culturing environments. We compared the biologic behavior of DTSCs isolated either by
 enzymatic dissociation (DTSCs-ED) or by direct outgrowth from pulp tissue explants (DTSCs-OG). We found that different isolation
 methods give rise to different populations/lineages of cells with respect to their phenotypic and differentiation characteristics.
 DTSCs-ED ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4269168</comments>
            <pubDate>Tue, 14 Dec 2010 06:44:00 +0100</pubDate>
            <guid isPermaLink="false">4269168</guid>        </item>
        <item>
            <title>Strontium Is Incorporated into the Fracture Callus but Does Not Influence the Mechanical Strength of Healing Rat Fractures</title>
            <link>http://www.medworm.com/index.php?rid=4247393&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff680x3rp11681211%2F</link>
            <description>In conclusion, SrR stimulates
 callus formation but has no effect on callus remodeling. Sr is incorporated into the newly formed callus tissue, but this
 has no deteriorating effect on the mechanical properties of rat tibial fractures at either the macroscopic or nanoscopic level
 after 3 or 8&amp;nbsp;weeks of healing.
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s00223-010-9439-zAuthors
		Annemarie Brüel, Institute of Anatomy, Aarhus University, Wilhelm Meyers Allé 3, Building 1233, 8000 Aarhus C, DenmarkJakob Olsen, Interdisciplinary Nanoscience Center, Aarhus University, Aarhus, DenmarkHenrik Birkedal, Interdisciplinary Nanoscience Center, Aarhus University, Aarhus, DenmarkMalene Risager, Institute of Anatomy, Aarhus University, Wilhelm Meyers Allé 3, Building 1233, 8000 Aarhu...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4247393</comments>
            <pubDate>Wed, 08 Dec 2010 18:09:13 +0100</pubDate>
            <guid isPermaLink="false">4247393</guid>        </item>
        <item>
            <title>Effect of Raloxifene on Arthritis and Bone Mineral Density in Rats with Collagen-Induced Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=4243443&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq5003u0243576337%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We studied the effect of raloxifene (RAL) on arthritis and bone mineral density (BMD) in rats with collagen-induced arthritis
 (CIA). Seven-month-old female Sprague–Dawley rats were divided into five groups: rats without CIA (CNT), CIA rats that underwent
 ovariectomy (OVX) and were treated with RAL (CIA&amp;nbsp;+&amp;nbsp;OVX&amp;nbsp;+&amp;nbsp;RAL), CIA rats that underwent OVX and were treated with vehicle (CIA&amp;nbsp;+&amp;nbsp;OVX&amp;nbsp;+&amp;nbsp;Veh),
 CIA rats that had sham surgery and were treated with RAL (CIA&amp;nbsp;+&amp;nbsp;sham&amp;nbsp;+&amp;nbsp;RAL), and CIA rats that had sham surgery and were treated
 with vehicle (CIA&amp;nbsp;+&amp;nbsp;sham&amp;nbsp;+&amp;nbsp;Veh). RAL was orally administered at 10&amp;nbsp;mg/kg every day for 3&amp;nbsp;weeks, beginning 1&amp;nbsp;week after initial
 sensitization until death a...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4243443</comments>
            <pubDate>Tue, 07 Dec 2010 13:45:28 +0100</pubDate>
            <guid isPermaLink="false">4243443</guid>        </item>
        <item>
            <title>Lactase Gene C/T−13910 Polymorphism, Calcium Intake, and pQCT Bone Traits in Finnish Adults</title>
            <link>http://www.medworm.com/index.php?rid=4239700&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F425288167w3kk7h1%2F</link>
            <description>In conclusion, the C/T−13910 polymorphism was associated with trabecular density at the distal radius and tibia in men. These differences may be due to
 the differences in calcium intake between the lactase genotypes.
 
 
	Content Type Journal ArticleDOI 10.1007/s00223-010-9440-6Authors
		Sanna Tolonen, Division of Nutrition, Department of Food and Environmental Sciences, University of Helsinki, P.O. Box 66, 00014 Helsinki, FinlandMarika Laaksonen, Division of Nutrition, Department of Food and Environmental Sciences, University of Helsinki, P.O. Box 66, 00014 Helsinki, FinlandVera Mikkilä, Division of Nutrition, Department of Food and Environmental Sciences, University of Helsinki, P.O. Box 66, 00014 Helsinki, FinlandHarri Sievänen, UKK Institute, Tampere, FinlandNina Mononen, Departme...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4239700</comments>
            <pubDate>Mon, 06 Dec 2010 18:44:15 +0100</pubDate>
            <guid isPermaLink="false">4239700</guid>        </item>
        <item>
            <title>Vitamin K2 Prevents Hyperglycemia and Cancellous Osteopenia in Rats with Streptozotocin-Induced Type 1 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=4239701&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk32ht7375m874026%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The purpose of the present study was to examine the effect of vitamin K2 on cancellous and cortical bone mass in rats with streptozotocin (STZ)-induced type 1 diabetes. Twenty-seven male Sprague-Dawley
 rats aged 12&amp;nbsp;weeks were randomized by the weight-stratified method into the following three groups: age-matched control group,
 STZ&amp;nbsp;+&amp;nbsp;vehicle group, and STZ&amp;nbsp;+&amp;nbsp;vitamin K2 group. STZ (40&amp;nbsp;+&amp;nbsp;50&amp;nbsp;mg/kg) was administered intravenously twice during the initial 1-week period. Vitamin K2 (menatetrenone, 30&amp;nbsp;mg/kg) was administered orally 5&amp;nbsp;days a week. After 12&amp;nbsp;weeks of treatment, the serum glucose concentration
 and femoral length and weight were measured and histomorphometric analysis was performed on the cancellous and corti...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4239701</comments>
            <pubDate>Mon, 06 Dec 2010 18:44:14 +0100</pubDate>
            <guid isPermaLink="false">4239701</guid>        </item>
        <item>
            <title>The Role of GH/IGF-I-Mediated Mechanisms in Sex Differences in Cortical Bone Size in Mice</title>
            <link>http://www.medworm.com/index.php?rid=4206654&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F87266834l6828376%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cortical bone dimensions are important determinants of bone strength. Gender differences in cortical bone size caused by greater
 periosteal expansion in males than in females during the pubertal growth spurt are well established both in humans and in
 experimental animal models. However, the mechanism by which gender influences cortical bone size is still a matter of investigation.
 The role of androgens and estrogen in pubertal bone growth has been examined in human disorders as well as animal models,
 such as gonadectomized or sex steroid receptor knockout mice. Based on the findings that growth hormone (GH) and insulin-like
 growth factor I (IGF-I) are major regulators of postnatal skeletal growth, we and others have predicted that sex hormones
 interact with the GH...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4206654</comments>
            <pubDate>Fri, 26 Nov 2010 18:04:21 +0100</pubDate>
            <guid isPermaLink="false">4206654</guid>        </item>
        <item>
            <title>Multicomponent Training Program with Weight-Bearing Exercises Elicits Favorable Bone Density, Muscle Strength, and Balance Adaptations in Older Women</title>
            <link>http://www.medworm.com/index.php?rid=4206655&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff1x71g507778571v%2F</link>
            <description>In this study we
 examined the effects of 8-month multicomponent training with weight-bearing exercises on different risk factors of falling,
 including muscle strength, balance, agility, and bone mineral density (BMD) in older women. Participants were randomly assigned
 to either an exercise-training group (ET, n&amp;nbsp;=&amp;nbsp;30) or a control group (CON, n&amp;nbsp;=&amp;nbsp;30). Twenty-seven subjects in the ET group and 22 in the CON group completed the study. Training was performed twice a
 week and was designed to load bones with intermittent and multidirectional compressive forces and to improve physical function.
 Outcome measures included lumbar spine and proximal femoral BMD (by dual X-ray absorptiometry), muscle strength, balance,
 handgrip strength, walking performance, fat mass, and ant...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4206655</comments>
            <pubDate>Fri, 26 Nov 2010 18:04:19 +0100</pubDate>
            <guid isPermaLink="false">4206655</guid>        </item>
        <item>
            <title>Osteoclasts Lacking Rac2 Have Defective Chemotaxis and Resorptive Activity</title>
            <link>http://www.medworm.com/index.php?rid=4206656&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnx0v27qj6637q732%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The role of the small Rho GTPase Rac2 in mature osteoclasts has not been extensively studied. Rac2−/− mice are of normal size and have normal tooth eruption. However, femoral cortical thickness was significantly greater in
 Rac2−/− compared to wild-type mice, while percent cortical porosity was lower. As assessed by histomorphometry, trabecular bone mass
 was significantly higher in male Rac2−/− than wild-type animals, although trabecular bone mass was similar when data from male and female animals were combined. There
 were no significant differences in the number of osteoblasts per bone surface; however, the number of osteoclasts per total
 bone area tended to be higher in Rac2−/− mice and was significantly higher in male Rac2−/− mice. In the aggre...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4206656</comments>
            <pubDate>Thu, 25 Nov 2010 20:05:38 +0100</pubDate>
            <guid isPermaLink="false">4206656</guid>        </item>
        <item>
            <title>Contribution of a Common Variant in the Promoter of the 1-α-Hydroxylase Gene (CYP27B1) to Fracture Risk in the Elderly</title>
            <link>http://www.medworm.com/index.php?rid=4201735&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F218q1772220v7653%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;
 CYP27B1 encodes mitochondrial 1α-hydroxylase, which converts 25-hydroxyvitamin D to its active 1,25-dihydroxylated metabolite. We
 tested the hypothesis that common variants in the CYP27B1 promoter are associated with fracture risk. The study was designed as a population-based genetic association study, which
 involved 153 men and 596 women aged 65–101&amp;nbsp;years, who had been followed for 2.2&amp;nbsp;years (range 0.1–5.5) between 1999 and 2006.
 During the follow-up period, the incidence of fragility fractures was ascertained. Bone ultrasound attenuation (BUA) was measured
 in all individuals, as were serum 25-hydroxyvitamin D and PTH concentrations; 86% subjects had vitamin D insufficiency. Genotypes
 were determined for the –1260C&amp;gt;A (rs10877012) and +2838T&amp;g...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4201735</comments>
            <pubDate>Wed, 24 Nov 2010 18:49:53 +0100</pubDate>
            <guid isPermaLink="false">4201735</guid>        </item>
        <item>
            <title>Inorganic Phosphate Induces Mammalian Growth Plate Chondrocyte Apoptosis in a Mitochondrial Pathway Involving Nitric Oxide and JNK MAP Kinase</title>
            <link>http://www.medworm.com/index.php?rid=4198553&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F63682q72575351r7%2F</link>
            <description>This study examined the mechanism by which Pi induces NO production
 and the signaling pathways by which NO mediates its effects on apoptosis in these cells. Pi decreased the number of viable
 cells based on MTT activity; the number of TUNEL-positive cells and the level of DNA fragmentation were increased, indicating
 an increase in apoptosis. Blocking NO production using the NO synthase (NOS) inhibitor l-NAME or cells from eNOS−/− mice blocked Pi-induced chondrocyte apoptosis, indicating that NO production is necessary. NO donors NOC-18 and SNOG both
 induced chondrocyte apoptosis. SNOG also upregulated p53 expression, the Bax/Bcl-2 expression ratio, and cytochrome c release from mitochondria, as well as caspase-3 activity, indicating that NO induces apoptosis via a mitochondrial path...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4198553</comments>
            <pubDate>Mon, 22 Nov 2010 13:27:24 +0100</pubDate>
            <guid isPermaLink="false">4198553</guid>        </item>
        <item>
            <title>Improvement of Femoral Bone Quality After Low-Magnitude, High-Frequency Mechanical Stimulation in the Ovariectomized Rat as an Osteopenia Model</title>
            <link>http://www.medworm.com/index.php?rid=4141639&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqr245363q4ln1100%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The treatment and prevention of osteoporosis involve great challenges. Nonpharmacological and supportive therapy procedures,
 sport, and physical exercises seem to prevent bone loss and improve bone mass. In the present study, we examined the effect
 of whole-body vertical vibration (WBVV) on femoral intertrochanteric bone quality in the rat osteoporosis model. Sixty female
 Sprague–Dawley rats, 3-month old, were ovariectomized (OVX) or sham-operated. After 3 months, each group was divided into
 two subgroups. In one of the subgroups, rats were treated with WBVV at 90&amp;nbsp;Hz (3.9&amp;nbsp;g) for 35 days; the second subgroup remained
 untreated. After killing the animals, biomechanical strength and trabecular bone architecture of the proximal region of femurs
 were analyz...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4141639</comments>
            <pubDate>Fri, 05 Nov 2010 10:50:23 +0100</pubDate>
            <guid isPermaLink="false">4141639</guid>        </item>
        <item>
            <title>Women with Cardiovascular Disease Have Increased Risk of Osteoporotic Fracture</title>
            <link>http://www.medworm.com/index.php?rid=4141640&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F45l610n7475414l4%2F</link>
            <description>This study investigated whether women with cardiovascular disease (CVD) would have an increased risk of fractures as osteoporosis
 and CVD share many common risk factors. From February 2006 to January 2007, 17,033 women aged ≥50&amp;nbsp;years (mean 71.8, range
 50–106) were recruited by 1,248 primary care practitioners and interviewed by trained nurses. For each woman, 10-year probability
 of a future major osteoporotic fracture was estimated using the World Health Organization Fracture Risk Assessment Tool (FRAX).
 The study showed that the 10-year probability of a major osteoporotic fracture was higher for 6,219 CVD women compared to
 10,814 non-CVD women after adjustment for age, BMI, current smoking, and alcohol use (adjusted geometric means 14.3 and 13.8%,
 respectively; P&amp;nbsp;&amp;lt;&amp;...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4141640</comments>
            <pubDate>Wed, 03 Nov 2010 07:55:09 +0100</pubDate>
            <guid isPermaLink="false">4141640</guid>        </item>
        <item>
            <title>Imatinib Mesylate Does Not Increase Bone Volume In Vivo</title>
            <link>http://www.medworm.com/index.php?rid=4112858&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn71042712r637807%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Imatinib mesylate is a tyrosine kinase inhibitor used in the management of disorders in which activation of c-Abl, PDGFR,
 or c-Kit signaling plays a critical role. In vitro, imatinib stimulates osteoblast differentiation, inhibits osteoblast proliferation
 and survival, and decreases osteoclast development. Patients treated with imatinib exhibit altered bone and mineral metabolism,
 with stable or increased bone mass. However, recovery from the underlying disease and/or weight gain might contribute to these
 effects. We therefore investigated the skeletal effects of imatinib in healthy rats. We evaluated the effects of imatinib
 on bone volume, markers of bone turnover, and bone histomorphometry in mature female rats treated for 5&amp;nbsp;weeks with either
 vehicle, imati...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4112858</comments>
            <pubDate>Tue, 26 Oct 2010 16:44:59 +0100</pubDate>
            <guid isPermaLink="false">4112858</guid>        </item>
        <item>
            <title>Lipid Profiles and Bone Mineral Density in Pre- and Postmenopausal Women in Korea</title>
            <link>http://www.medworm.com/index.php?rid=4112859&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp362245415283kr6%2F</link>
            <description>This study considered 10,402 women who underwent measurements of lipid
 profile and BMD from October 2003 to October 2005 at Healthcare System Gangnam Center, Seoul National University Hospital.
 Participants with potential confounding factors affecting BMD (n&amp;nbsp;=&amp;nbsp;3,128) were excluded. The associations between lipid profiles (total cholesterol [TC], low-density lipoprotein [LDL-C]
 and high-density lipoprotein [HDL-C] cholesterol, and triglyceride [TG]) and BMD at various skeletal sites (lumbar spine [L1–L4],
 proximal total hip, femoral neck, and trochanter) were explored by Pearson’s correlation and partial correlation, adjusting
 for age, body mass index, and menarche age. Multiple linear regression analyses adjusting for all other covariates were also
 performed. Data on 4,...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4112859</comments>
            <pubDate>Tue, 26 Oct 2010 06:49:11 +0100</pubDate>
            <guid isPermaLink="false">4112859</guid>        </item>
        <item>
            <title>Erratum to: Risk of Upper Gastrointestinal Tract Events in Risedronate Users Switched to Alendronate</title>
            <link>http://www.medworm.com/index.php?rid=4112860&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh2r04u6874u76646%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s00223-010-9430-8Authors
		Stuart H. Ralston, Rheumatic Diseases Unit, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, EH4 2XU UKTzuyung D. Kou, Procter &amp; Gamble Pharmaceuticals, Inc., Mason, OH USABettina Wick-Urban, Procter &amp; Gamble Pharmaceuticals, Inc., Mason, OH USAMichael Steinbuch, Procter &amp; Gamble Pharmaceuticals, Inc., Mason, OH USATahir Masud, Nottingham University Hospitals NHS Trust, Nottingham, UK
	

	
		Journal Calcified Tissue InternationalOnline ISSN 1432-0827Print ISSN 0171-967X (Source: Calcified Tissue International)</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4112860</comments>
            <pubDate>Sat, 23 Oct 2010 15:45:58 +0100</pubDate>
            <guid isPermaLink="false">4112860</guid>        </item>
        <item>
            <title>Muscle Changes Can Account for Bone Loss After Botulinum Toxin Injection</title>
            <link>http://www.medworm.com/index.php?rid=4092206&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8r8443j3x1552w18%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Studies to date have assumed that botulinum toxin type A (BTX) affects bone indirectly, through its action on muscle. We hypothesized
 that BTX has no discernable effect on bone morphometry, independent of its effect on muscle. Therefore, we investigated whether
 BTX had an additional effect on bone when combined with tenotomy compared to tenotomy in isolation. Female BALB/c mice (n&amp;nbsp;=&amp;nbsp;73) underwent one of the following procedures in the left leg: BTX injection and Achilles tenotomy (BTX-TEN), BTX injection
 and sham surgery (BTX-sham), Achilles tenotomy (TEN), or sham surgery (sham). BTX groups were injected with 20 μL of BTX (1
 U/100&amp;nbsp;g) in the posterior lower hindlimb. At 4&amp;nbsp;weeks, muscle cross-sectional area (MCSA) and tibial bone morphometry were...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4092206</comments>
            <pubDate>Thu, 21 Oct 2010 17:13:36 +0100</pubDate>
            <guid isPermaLink="false">4092206</guid>        </item>
        <item>
            <title>Normative Calcaneal Quantitative Ultrasound Data as an Estimation of Skeletal Development in Swedish Children and Adolescents</title>
            <link>http://www.medworm.com/index.php?rid=4092207&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F236hpn7060n8vk07%2F</link>
            <description>We present age- and gender-specific normative bone status data evaluated by quantitative ultrasound (QUS) in the calcaneus
 with the Lunar Achilles device and compare these estimates with bone mineral content (BMC) and bone mineral density (BMD)
 estimated by dual X-ray absorptiometry (DXA). Included were a sample of 518 population-based collected Swedish girls and 558
 boys aged 6–19&amp;nbsp;years. QUS measurements included speed of sound (SOS), broadband ultrasound attenuation (BUA), and stiffness
 index (SI) in the calcaneus. DXA measurements included BMC and BMD in the femoral neck (FN), lumbar spine (L2–L4), and total
 body (TB). Height and weight were measured with standard equipment. Age, height, and weight were significantly associated
 with SOS, BUA, and SI. Compared to SOS, in b...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4092207</comments>
            <pubDate>Tue, 19 Oct 2010 23:21:52 +0100</pubDate>
            <guid isPermaLink="false">4092207</guid>        </item>
        <item>
            <title>Effects of Nicotine Administration and Nicotine Cessation on Bone Histomorphometry and Bone Biomarkers in Sprague–Dawley Male Rats</title>
            <link>http://www.medworm.com/index.php?rid=4083926&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3t5653u1711r5647%2F</link>
            <description>In conclusion, nicotine administration
 at a dose of 7&amp;nbsp;mg/kg for 2 and 4&amp;nbsp;months has detrimental effects on bone metabolism. Nicotine administration at 7&amp;nbsp;mg/kg for
 2&amp;nbsp;months is sufficient to produce significant effects on bone histomorphometric parameters and biomarkers. In addition, prolonging
 the treatment for another 2&amp;nbsp;months did not show any significant differences. Cessation of nicotine for 2&amp;nbsp;months did not reverse
 the effects.
 
 
	Content Type Journal ArticleDOI 10.1007/s00223-010-9426-4Authors
		Hermizi Hapidin, Biomedicine Program, School of Health Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan MalaysiaFaizah Othman, Department of Anatomy, UKM Medical Centre, Universiti Kebangsaan Malaysia, Jln. Raja Muda Abdul Aziz...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4083926</comments>
            <pubDate>Sat, 16 Oct 2010 07:46:57 +0100</pubDate>
            <guid isPermaLink="false">4083926</guid>        </item>
        <item>
            <title>Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=4083925&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk21154553683l523%2F</link>
            <description>This report describes the pharmacokinetics and resulting serum calcium response to teriparatide in postmenopausal
 women with osteoporosis. Pharmacokinetic samples for this analysis were obtained from 360 women who participated in the Fracture
 Prevention Trial. Postmenopausal women with osteoporosis received daily subcutaneous injections of either teriparatide 20&amp;nbsp;μg
 (4.86&amp;nbsp;μmol) or placebo, median 21&amp;nbsp;months’ treatment. Serum teriparatide and calcium concentrations were measured throughout
 the study. An indirect-response model was developed to describe the pharmacokinetic–pharmacodynamic relationship between teriparatide
 concentrations and serum calcium response. The pharmacokinetics of teriparatide were characterized by rapid absorption (maximum
 concentration achie...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4083925</comments>
            <pubDate>Sat, 16 Oct 2010 07:46:57 +0100</pubDate>
            <guid isPermaLink="false">4083925</guid>        </item>
        <item>
            <title>Comparative Study on Measured Variables and Sensitivity to Bone Microstructural Changes Induced by Weightlessness Between In Vivo and Ex Vivo Micro-CT Scans</title>
            <link>http://www.medworm.com/index.php?rid=4026406&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fql81jj4436340587%2F</link>
            <description>In this study we investigated if differences exist in the variables measured by micro-CT between in vivo and ex vivo scans
 and which kind of scan is more sensitive to the changes of bone microstructure induced by simulated weightlessness. Rat tail
 suspension was used to simulate the weightless condition. The same bone from either normal or tail-suspended rats was scanned
 by micro-CT both in vivo and ex vivo (fresh and fixed by formalin). Then, bone mineral density (BMD) and microstructural characteristics
 were analyzed. The results showed that no significant differences existed in the microstructural parameters of trabecular
 bone among in vivo, fresh, and formalin-fixed bone scans from both femurs and tibias, although BMD exhibited differences.
 On the other hand, most parameters of t...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4026406</comments>
            <pubDate>Fri, 01 Oct 2010 07:11:57 +0100</pubDate>
            <guid isPermaLink="false">4026406</guid>        </item>
        <item>
            <title>Continuous Treatment with a Low-Dose β-Agonist Reduces Bone Mass by Increasing Bone Resorption Without Suppressing Bone Formation</title>
            <link>http://www.medworm.com/index.php?rid=4024560&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk4326t2245p0w36r%2F</link>
            <description>In this study, we examined the dose effect
 of continuous treatment with isoprenaline, a nonspecific β-AR agonist, on bone remodeling. Male C57BL/6J mice were intrasubcutaneously
 administrated with four different doses (5, 25, 50, or 100&amp;nbsp;μg/g daily) of isoprenaline or vehicle using an osmotic pump for
 2&amp;nbsp;weeks. The region of high-turnover cancellous bone was analyzed by microcomputed tomography (μCT). Continuous isoprenaline
 treatment caused a ~35.7% decline in the femoral cancellous bone volume fraction (BV/TV) at all doses (5–100&amp;nbsp;μg/g daily).
 Furthermore, continuous isoprenaline treatment weakened the bone mechanical properties in the trunk of lumbar vertebra 4 (L4).
 These parameters did not show significant differences between doses. Histomorphometric analysis r...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4024560</comments>
            <pubDate>Thu, 30 Sep 2010 07:51:05 +0100</pubDate>
            <guid isPermaLink="false">4024560</guid>        </item>
        <item>
            <title>Integration of Phosphatidylinositol 3-Kinase, Akt Kinase, and Smad Signaling Pathway in BMP-2-Induced Osterix Expression</title>
            <link>http://www.medworm.com/index.php?rid=4007855&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Frk777qx761507p42%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Osterix (Osx), a BMP-2-regulated transcription factor, controls expression of genes essential for osteoblast differentiation.
 Using progressive deletion of the Osx promoter, we characterized a Smad binding element (SBE) between −552 and −839&amp;nbsp;bp from
 its transcription start site. Electrophoretic mobility shift assay and chromatin immunoprecipitation assay showed binding
 and in vivo recruitment of Smads 1 and 5 to the Osx SBE. Inactivation of PI 3-kinase by the pharmacologic inhibitor Ly294002
 or by dominant negative (DN) enzyme significantly blocked BMP-2-induced Osx protein and mRNA expression and Osx transcription.
 Finally, both DN PI 3-kinase and DN Akt significantly attenuated Smad 5-dependent transcription of Osx, demonstrating the
 first evidence for ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4007855</comments>
            <pubDate>Sat, 25 Sep 2010 16:57:28 +0100</pubDate>
            <guid isPermaLink="false">4007855</guid>        </item>
        <item>
            <title>Impact of Treatments for Postmenopausal Osteoporosis (Bisphosphonates, Parathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review</title>
            <link>http://www.medworm.com/index.php?rid=4007856&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq4536533232q6754%2F</link>
            <description>The objective of this systematic review was to examine the influence of treatments for postmenopausal osteoporosis (parathyroid
 hormone [PTH], bisphosphonates, strontium ranelate, and denosumab) on bone quality and discuss the clinical implications.
 Most bone-quality data for PTH is from teriparatide. Teriparatide results in a rapid increase in bone-formation markers, followed
 by increases in bone-resorption markers, opening an “anabolic window,” a period of time when PTH is maximally anabolic. Teriparatide
 reverses the structural damage seen in osteoporosis and restores the structure of trabecular bone. It has a positive effect
 on cortical bone, and any early increases in cortical porosity appear to be offset by increases in cortical thickness and
 diameter. Bisphosphonates are a...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4007856</comments>
            <pubDate>Sat, 25 Sep 2010 16:57:26 +0100</pubDate>
            <guid isPermaLink="false">4007856</guid>        </item>
        <item>
            <title>Jaw and Long Bone Marrows Have a Different Osteoclastogenic Potential</title>
            <link>http://www.medworm.com/index.php?rid=3996237&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh86w725846610505%2F</link>
            <description>In conclusion, bone
 marrow cells from different skeletal locations (jaw and long bone) have different dynamics of osteoclastogenesis. We propose
 that this is primarily due to differences in the cellular composition of the bone site-specific marrow.
 
 
	Content Type Journal ArticleDOI 10.1007/s00223-010-9418-4Authors
		Ana Paula de Souza Faloni, Department of Morphology and Genetics, Federal University of São Paulo (UNIFESP), Rua Botucatu, 740 Vila Clementino, São Paulo, SP 04023-900, BrazilTon Schoenmaker, Department of Oral Cell Biology and Periodontology, Academic Center of Dentistry Amsterdam (ACTA), Research Institute Move, University of Amsterdam and VU University Amsterdam, Gustav Mahlerlaan 3004, 1081 LA Amsterdam, The NetherlandsAzin Azari, Department of Oral Cell Biology and ...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3996237</comments>
            <pubDate>Wed, 22 Sep 2010 16:42:08 +0100</pubDate>
            <guid isPermaLink="false">3996237</guid>        </item>
        <item>
            <title>Effects of Smoking on Severity of Disease in Primary Hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=3996238&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1r3074287l776t61%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In healthy subjects, smoking is associated with lower plasma levels of parathyroid hormone (PTH) and decreased bone mineral
 density (BMD). The effect of smoking on PTH, skeletal metabolism, and size/histology of the parathyroid glands in primary
 hyperparathyroidism (PHPT) is unknown. We investigated, in a cross-sectional study, whether smoking affects PTH levels, BMD,
 and weight/histology of removed parathyroid tissue in PHPT. We studied 344 (285 women) parathyroidectomized patients with
 PHPT (24% smokers). Biochemistry was determined at the time of diagnosis. BMD was measured before and after surgical cure.
 Smoking was associated with lower PTH (9.9&amp;nbsp;±&amp;nbsp;1.8 [SD] vs. 12.2&amp;nbsp;±&amp;nbsp;1.8&amp;nbsp;pmol/l, P&amp;nbsp;&amp;lt;&amp;nbsp;0.01) and higher phosphate (0.95&amp;nbsp;...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3996238</comments>
            <pubDate>Wed, 22 Sep 2010 16:42:06 +0100</pubDate>
            <guid isPermaLink="false">3996238</guid>        </item>
        <item>
            <title>The Biphenyl-Carboxylate Derivative ABD328 is a Novel Orally Active Antiresorptive Agent</title>
            <link>http://www.medworm.com/index.php?rid=3981670&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvn8x3k67180322q2%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We previously described a novel series of biphenyl carboxylic acid derivatives which have potent antiresorptive effects in
 vitro and in vivo and do not affect osteoblast function. However, none of the previous compounds showed oral activity, probably
 because they were esters, which would be expected to be metabolized very rapidly. Here, we tested whether derivatives where
 the ester link was replaced by a ketone link were orally active. Compounds were tested in murine osteoclast and osteoblast
 cultures and in the mouse ovariectomy (OVX) model of osteoporosis. The ketones were at least as potent at inhibiting osteoclast
 formation and RANKL signaling in vitro as the esters and did not inhibit osteoblast differentiation or function. The basic
 ketone-linked compound AB...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3981670</comments>
            <pubDate>Fri, 17 Sep 2010 16:52:22 +0100</pubDate>
            <guid isPermaLink="false">3981670</guid>        </item>
        <item>
            <title>Three-Dimensional Cortical Bone Microstructure in a Rat Model of Hypoxia-Induced Growth Retardation</title>
            <link>http://www.medworm.com/index.php?rid=3978858&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F93315430w1w67722%2F</link>
            <description>In this study, we examined the effect of chronic hypoxia on the canal network in postnatal
 bone. Tibiae were harvested from 4- and 8-week-old rats (hyp-4 and -8, n&amp;nbsp;=&amp;nbsp;8 each), whose growth was retarded owing to postnatal exposure to hypoxia (12–14% O2), and from 3- and 4-week-old normoxic rats (cnt-4 and -5, n&amp;nbsp;=&amp;nbsp;8 each), which were similar in tibial length and cortical cross-sectional area to hyp-4 and -8, respectively. The diaphyseal
 canals were detected by monochromatic synchrotron radiation CT with a 3.1-μm voxel resolution. The anatomical properties of
 the canal network were compared between age- or size-matched hypoxic and normoxic groups. The canals were larger in diameter,
 were more densely distributed and connected, and opened into the marrow cavity with a...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3978858</comments>
            <pubDate>Thu, 16 Sep 2010 16:46:21 +0100</pubDate>
            <guid isPermaLink="false">3978858</guid>        </item>
        <item>
            <title>Potential of Resveratrol Analogues as Antagonists of Osteoclasts and Promoters of Osteoblasts</title>
            <link>http://www.medworm.com/index.php?rid=3978859&amp;cid=s_33438_31_f&amp;fid=33438&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F38xj0124g111721h%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The plant phytoalexin resveratrol was previously demonstrated to inhibit the differentiation and bone resorbing activity of
 osteoclasts, to promote the formation of osteoblasts from mesenchymal precursors in cultures, and inhibit myeloma cell proliferation,
 when used at high concentrations. In the current study, we screened five structurally modified resveratrol analogues for their
 ability to modify the differentiation of osteoclasts and osteoblasts and proliferation of myeloma cells. Compared to resveratrol,
 analogues showed an up to 5,000-fold increased potency to inhibit osteoclast differentiation. To a lesser extent, resveratrol
 analogues also promoted osteoblast maturation. However, they did not antagonize the proliferation of myeloma cells. The potency
 of th...</description>
            <author>Calcified Tissue International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3978859</comments>
            <pubDate>Tue, 14 Sep 2010 18:08:28 +0100</pubDate>
            <guid isPermaLink="false">3978859</guid>        </item>
    </channel>
</rss>

